Novel borate compound-containing composition

A borate compound composition with specific base compounds addresses solubility and catalyst poisoning issues, ensuring efficient olefin and diene polymerization by being soluble in hydrocarbon solvents and preventing catalyst deactivation.

JP7582292B2Active Publication Date: 2024-11-13AGC INC
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
JP2022507205
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-12-17
Filing Date
2021-03-09
Publication Date
2024-11-13
Estimated Expiration
2041-03-09

AI Technical Summary

Technical Problem

Existing borate compounds used as cocatalysts for olefin and diene polymerization are poorly soluble in hydrocarbon solvents, particularly aliphatic hydrocarbons, and can act as catalyst poisons, leading to inefficient polymerization reactions.

Method used

A borate compound-containing composition is developed, comprising specific base compounds that are soluble in hydrocarbon solvents, especially aliphatic hydrocarbons, and are formulated to avoid catalyst poisoning, using specific base A compounds with a total carbon number of 25 or more, represented by formulas (1) and (5), and a production method that ensures minimal residual impurities.

Benefits of technology

The composition achieves solubility in hydrocarbon solvents, preventing catalyst poisoning and enhancing the efficiency of olefin and diene polymerization reactions.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007582292000001
    Figure 0007582292000001
  • Figure 0007582292000002
    Figure 0007582292000002
  • Figure 0007582292000003
    Figure 0007582292000003
Patent Text Reader

Abstract

The purpose of the present invention is to provide: a borate compound-containing composition which is useful as a promoter for polymerization of olefins or dienes and which is soluble in a hydrocarbon solvent; and a manufacturing method therefor. The present invention pertains to a composition containing a base A or a compound having eight or more total carbon atoms and represented by formula (5), (Definitions of the symbols in the formula are as disclosed in the specification.) and a borate compound represented by formula (1). (Definitions of the symbols in the formula are as disclosed in the specification.) The present invention additionally pertains to a manufacturing method for the composition.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a composition containing a borate compound and a base, which is useful as a cocatalyst for the polymerization of olefins and dienes, and a method for producing the same. [Background technology]

[0002] There have been many reports of the use of non-metallocene metal complex catalysts such as metallocene compounds, diimine complexes, and phenoxy complexes as polymerization catalysts for olefins and dienes. In many of the catalyst systems using these metal complex catalysts, methylaluminoxane and tetrakis(pentafluorophenyl)borate compounds are used as cocatalysts to stabilize the active species. Tetrakis(pentafluorophenyl)borate compounds are widely used as cocatalysts in solution polymerization systems because they have better thermal stability than methylaluminoxane and can be used in a smaller stoichiometric ratio to the metal complex than methylaluminoxane.

[0003] In addition, non-polar hydrocarbon solvents are used as solvents for the polymerization of olefins and dienes using metal complex catalysts. In particular, from the standpoint of odor and toxicity, aromatic hydrocarbon solvents such as toluene are being replaced by aliphatic hydrocarbon solvents such as hexane.

[0004] However, it is known that ordinary tetrakis(pentafluorophenyl)borate compounds are poorly soluble in aromatic hydrocarbon solvents such as toluene, and even if they dissolve, they separate into two liquid-liquid phases: a concentrated phase in which the borate compound is dissolved and a dilute phase in which the borate compound is not dissolved (Patent Document 1).

[0005] In addition, because normal tetrakis(pentafluorophenyl)borate compounds are poorly soluble in aliphatic hydrocarbon solvents such as hexane and heptane, tetrakis(pentafluorophenyl)borate compounds that are soluble in aliphatic hydrocarbon solvents are desired and have been proposed (Patent Document 2). Di(octadecyl)methylammonium tetrakis(pentafluorophenyl)borate and bis(hydrogenated tallow alkyl)methylammonium tetrakis(pentafluorophenyl)borate described in Patent Document 2 are useful as compounds that are easily soluble in hydrocarbon solvents.

[0006] However, in the manufacturing method described in Patent Document 2, lithium tetrakis(pentafluorophenyl)borate is prepared by reacting with a hydrochloride of a dialkylmethylamine prepared separately, and in this method, the raw material lithium tetrakis(pentafluorophenyl)borate or hydrochloride of a long-chain aliphatic amine, which is poorly soluble in water, remains in the product, and there is a concern that these act as catalyst poisons and do not show sufficient activity when used as a polymerization cocatalyst. In fact, in Example 2 of Patent Document 2, diethyl ether remains in the product, and it is presumed that a diethyl ether complex of lithium tetrakis(pentafluorophenyl)borate, which is poorly soluble in water, remains.

[0007] Patent Document 3 discloses a method for producing an ammonium tetrakis(pentafluorophenyl)borate derivative, which comprises mixing an alkali metal salt of tetrakis(pentafluorophenyl)borate with an amine and then treating the mixture with a protonic acid. However, even with this method, there is concern that an ether complex of an alkali metal salt of tetrakis(pentafluorophenyl)borate or a protonic acid salt of a long-chain aliphatic amine remains in the product and acts as a catalyst poison.

[0008] Patent Document 4 discloses a composition containing a trialkylammonium tetrakis(pentafluorophenyl)borate compound and an amine compound, and a method for producing the composition, and discloses that the composition is soluble in a hydrocarbon solvent. However, trialkylamine, which is an amine compound described in Patent Document 4, is highly basic and nucleophilic, and therefore there is concern that it may be a catalyst poison for the polymerization reaction of olefins or dienes. [Prior art documents] [Patent documents]

[0009] [Patent Document 1] JP 2018-104335 A [Patent Document 2] Special Publication No. 2000-507157 [Patent Document 3] Special Publication No. 2007-530673 [Patent Document 4] JP 2019-59795 A Summary of the Invention [Problem to be solved by the invention]

[0010] In view of these conventional techniques, the present invention aims to provide a borate compound-containing composition which is soluble in hydrocarbon solvents, particularly aliphatic hydrocarbon solvents, and which does not act as a catalyst poison in the polymerization reaction of olefins or dienes, and an industrial process for producing the same. [Means for solving the problem]

[0011] As a result of extensive investigation, the present inventors have (I) a base A, or The following formula (5):

[0012] [ka]

[0013] [In the formula, R and R′ each independently represent an optionally substituted C1-30 Alkyl groups, optionally substituted C 3-15 Cycloalkyl group or optionally substituted C 6-14 represents an aryl group. Compounds having a total of 8 or more carbon atoms, (II) Formula (1):

[0014] [ka]

[0015] [In the formula, R 1 , R 2 , R 3 and R 4 Each independently represents one or more fluorine atoms or fluoro C 1-4 Alkyl-substituted C 6-14 represents an aryl group, and [AH] + represents a cation derived from base A. Here, the base A is (i) Two or more identical or different C 1-30 Alkyl group or C 1-30 Nitrogen-containing aromatic heterocyclic compounds having a total of 25 or more carbon atoms substituted with an alkoxy group, or (ii) Formula (2):

[0016] [ka]

[0017] (Wherein, Ar is optionally substituted C 6-14 represents an aryl group, and R 5 and R 6 each independently represents an optionally substituted C 1-30 represents an alkyl group; and represents an aromatic amine compound having a total of 25 or more carbon atoms. The present inventors have found for the first time that a composition containing a compound represented by the formula (hereinafter also referred to as the "composition of the present invention") is soluble in hydrocarbon solvents, particularly aliphatic hydrocarbon solvents, does not generate compounds that are catalyst poisons in the polymerization reaction of olefins or dienes, and is useful as a co-catalyst, and have completed the present invention.

[0018] That is, the present invention is as follows. [1] (I) a base A, or The following formula (5):

[0019] [ka]

[0020] [In the formula, R and R′ each independently represent an optionally substituted C 1-30 Alkyl groups, optionally substituted C 3-15 Cycloalkyl group or optionally substituted C 6-14 represents an aryl group. Compounds having a total of 8 or more carbon atoms, (II) Formula (1):

[0021] [ka]

[0022] [In the formula, R 1 , R 2 , R 3 and R 4 Each independently represents one or more fluorine atoms or fluoro C 1-4 Alkyl-substituted C 6-14 represents an aryl group, and [AH] + represents a cation derived from base A. Here, the base A is (i) Two or more identical or different C 1-30 Alkyl group or C 1-30 Nitrogen-containing aromatic heterocyclic compounds having a total of 25 or more carbon atoms substituted with an alkoxy group, or (ii) Formula (2):

[0023] [ka]

[0024] (Wherein, Ar is optionally substituted C 6-14 represents an aryl group, and R 5 and R 6 each independently represents an optionally substituted C 1-30 represents an alkyl group; and represents an aromatic amine compound having a total of 25 or more carbon atoms. A composition comprising a compound represented by the formula: [2] A base A and the following formula (1):

[0025] [ka]

[0026] [In the formula, R 1 , R 2 , R 3 and R 4 Each independently represents one or more fluorine atoms or fluoro C 1-4 Alkyl-substituted C 6-14 represents an aryl group, and [AH] + represents a cation derived from base A. Here, the base A is (i) Two or more identical or different C 1-30 Alkyl group or C 1-30 Nitrogen-containing aromatic heterocyclic compounds having a total of 25 or more carbon atoms substituted with an alkoxy group, or (ii) Formula (2):

[0027] [ka]

[0028] (Wherein, Ar is optionally substituted C 6-14represents an aryl group, and R 5 and R 6 each independently represents an optionally substituted C 1-30 represents an alkyl group; and represents an aromatic amine compound having a total of 25 or more carbon atoms. A composition comprising a compound represented by the formula: [2'] The composition according to [1] above, wherein the component (I) is a base A. [3] The composition according to the above [1], wherein component (I) is a compound represented by formula (5). [4]R 1 , R 2 , R 3 and R 4 are each independently substituted with one or more fluorine atoms or trifluoromethyl groups, and are a phenyl group, a 1-naphthyl group, a 2-naphthyl group, a 2-biphenylyl group, a 3-biphenylyl group, a 4-biphenylyl group, a 1-anthryl group, a 2-anthryl group, a 9-anthryl group, a 9-phenanthryl group, or a 3-phenanthryl group. [5] R 1 , R 2 , R 3 and R 4 The composition according to any one of the above [1] to [3], wherein all of are a pentafluorophenyl group, a 2,2',3,3',4',5,5',6,6'-nonafluoro-4-(1,1'-biphenylyl) group, a 2,3,4,5,6,7,8-heptafluoro-1-naphthyl group, or a 1,3,4,5,6,7,8-heptafluoro-2-naphthyl group. [6] The base A is a 2-mer of the same or different C 9-30 Alkyl group or C 9-30 The composition according to any one of the above [1], [2], [2'], [4] and [5], which is a 5- or 6-membered monocyclic nitrogen-containing aromatic heterocyclic compound having a total of 35 or more carbon atoms and substituted with an alkoxy group. [7] The composition according to [6] above, wherein the 5- or 6-membered monocyclic nitrogen-containing aromatic heterocyclic compound is pyridine or imidazole. [8] The base A is a 2-mer of the same or different C 9-30Alkyl group or C 9-30 The composition according to any one of [1], [2], [2'], [4] and [5], which is a bicyclic nitrogen-containing aromatic heterocyclic compound substituted with an alkoxy group and having a total of 25 or more carbon atoms. [9] The composition according to [8] above, wherein the bicyclic nitrogen-containing aromatic heterocyclic compound is benzimidazole.

[10] The base A is an aromatic amine compound having a total of 25 or more carbon atoms and represented by the formula (2), Ar is a halogen atom, C 1-30 Alkyl group, C 1-30 Alkoxy and haloC 1-6 a phenyl group optionally substituted with a substituent selected from the group consisting of alkyl groups, and R 5 and R 6 However, each independently, C 1-30 The composition according to any one of the above [1], [2], [2'], [4] and [5], wherein the group is an alkyl group.

[11] The composition according to any one of the above [1], [2], [2'] and [4] to

[10] , wherein the content of the base A is in the range of 0.01 to 10 moles relative to 1 mole of the compound represented by the formula (1).

[12] R and R' are each independently C 1-30 The composition according to any one of the above [1] and [3] to [5], wherein R is an alkyl group, and the total number of carbon atoms in R and R' is 8 or more.

[13] R and R' are each independently C 1-30 The composition according to any one of the above [1] and [3] to [5], wherein R is an alkyl group and R and R' have a total carbon number of 16 or more.

[14] The composition according to any one of the above [1], [3] to [5],

[12] and

[13] , wherein the content of the compound represented by the formula (5) is in the range of 0.1 to 10 moles per mole of the compound represented by the formula (1).

[15] A co-catalyst for polymerization of at least one monomer selected from the group consisting of olefins and dienes, comprising the composition according to any one of the above [1] to

[14] .

[16] Formula (3):

[0029] [ka]

[0030] [In the formula, R 1 , R 2 , R 3 and R 4 Each independently represents one or more fluorine atoms or fluoro C 1-4 Alkyl-substituted C 6-14 represents an aryl group. The method for producing the composition according to any one of the above [1], [2], [2'] and [4] to

[11] , further comprising a step of reacting a compound represented by formula (3) with the base A, wherein the amount of the base A used is more than 1 mole per mole of the compound represented by formula (3).

[17] The method according to

[16] above, wherein the amount of the base A used is in the range of 1.01 to 3 moles per mole of the compound represented by the formula (3).

[18] Equation (4):

[0031] [ka]

[0032] [In the formula, R 1 , R 2 , R 3 and R 4 Each independently represents one or more fluorine atoms or fluoro C 1-4 Alkyl-substituted C 6-14 represents an aryl group, M represents an alkali metal or an alkaline earth metal; and and n represents 1 or 2.], the base A, and a protonic acid are reacted together, and the base A is used in an amount exceeding 1 mole per mole of the compound represented by formula (4).

[19] Formula (4):

[0033] [ka]

[0034] [In the formula, R 1 , R 2 , R 3 and R 4 Each independently represents one or more fluorine atoms or fluoro C 1-4 Alkyl-substituted C 6-14 represents an aryl group, M represents an alkali metal or an alkaline earth metal; and and n represents 1 or 2.], a step of reacting 1 mole of the compound represented by formula (4) with 1 mole of the base A and a protonic acid, and then reacting a compound represented by formula (5):

[0035] [ka]

[0036] [In the formula, R and R′ each independently represent an optionally substituted C 1-30 Alkyl groups, optionally substituted C 3-15 Cycloalkyl group or optionally substituted C 6-14 represents an aryl group. The method for producing the composition according to any one of the above [1], [3] to [5], and

[12] to

[14] , comprising adding a compound having a total of 8 or more carbon atoms,

[20] A method for producing a polymer, comprising polymerizing at least one monomer selected from the group consisting of olefins and dienes by using the composition according to any one of the above [1] to

[14] as a co-catalyst. Effect of the Invention

[0037] According to the present invention, there can be provided a composition containing the borate compound, which is soluble in hydrocarbon solvents, particularly aliphatic hydrocarbon solvents, and is useful as a co-catalyst for the polymerization reaction of olefins or dienes, and a method for producing the same. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0038] The definitions of the terms and symbols used in this specification are explained below.

[0039] In this specification, the term "halogen atom" means a fluorine atom, a chlorine atom, a bromine atom or an iodine atom.

[0040] In this specification, the term "alkyl (group)" refers to a linear or branched alkyl group having one or more carbon atoms.

[0041] In this specification, "C 1-30 The term "alkyl (group)" refers to a straight-chain or branched-chain alkyl group having 1 to 30 carbon atoms, and examples thereof include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, neopentyl, 1-ethylpropyl, hexyl, isohexyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, 2-ethylbutyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, hexadecyl, octadecyl, nonadecyl, eicosyl, docosyl, tricosyl, tetracosyl, pentacosyl, hexacosyl, heptacosyl, octacosyl, nonacosyl, and triacontyl.

[0042] In this specification, "C 9-30 The term "alkyl (group)" means a straight-chain or branched-chain alkyl group having 9 to 30 carbon atoms, and examples thereof include nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, hexadecyl, octadecyl, nonadecyl, eicosyl, docosyl, tricosyl, tetracosyl, pentacosyl, hexacosyl, heptacosyl, octacosyl, nonacosyl, triacontyl, and the like.

[0043] In this specification, "C 1-6The term "alkyl (group)" refers to a straight-chain or branched-chain alkyl group having 1 to 6 carbon atoms, and examples thereof include methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, tert-butyl, pentyl, isopentyl, neopentyl, 1-ethylpropyl, hexyl, isohexyl, 1,1-dimethylbutyl, 2,2-dimethylbutyl, 3,3-dimethylbutyl, and 2-ethylbutyl. Among these, C 1-4 Alkyl groups are preferred.

[0044] As used herein, "HaloC 1-6 The alkyl group is defined as "C 1-6 It means a group in which one or more hydrogen atoms in the "alkyl" group are substituted with halogen. Specific examples include difluoromethyl, trifluoromethyl, 2-chloroethyl, 2-bromoethyl, 2-iodoethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, 2,2,3,3-tetrafluoropropyl, 3,3,3-trifluoropropyl, 4,4,4-trifluorobutyl, 5,5,5-trifluoropentyl, 6,6,6-trifluorohexyl, and the like. Among them, "haloC 1-4 Alkyl is preferred.

[0045] As used herein, "fluoro C 1-6 The term "alkyl (group)" refers to the above-mentioned "haloC 1-6 It means a group in which the halogen atom in the "alkyl" group is a fluorine atom. Specific examples include difluoromethyl, trifluoromethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, 2,2,3,3-tetrafluoropropyl, 3,3,3-trifluoropropyl, 4,4,4-trifluorobutyl, 5,5,5-trifluoropentyl, and 6,6,6-trifluorohexyl. Among them, "fluoro C" such as difluoromethyl, trifluoromethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, 2,2,3,3,3-pentafluoropropyl, 2,2,3,3-tetrafluoropropyl, 3,3,3-trifluoropropyl, and 4,4,4-trifluorobutyl is preferred.1-4 Alkyl (group) is preferred, difluoromethyl, trifluoromethyl, 2,2,2-trifluoroethyl, pentafluoroethyl or pentafluoroethyl is more preferred, and trifluoromethyl is particularly preferred.

[0046] In the present specification, the term "cycloalkyl (group)" refers to a cyclic alkyl group, and when there is no particular limitation on the carbon number range, it is preferably C 3-8 It is a cycloalkyl group.

[0047] In this specification, "C 3-8 The term "cycloalkyl (group)" refers to a cyclic alkyl group having 3 to 8 carbon atoms, and examples thereof include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. 3-6 Cycloalkyl groups are preferred.

[0048] As used herein, the term "alkoxy (group)" refers to a group in which a straight-chain or branched-chain alkyl group is bonded to an oxygen atom.

[0049] In this specification, "C 1-30 The term "alkoxy (group)" means a straight-chain or branched-chain alkoxy group having 1 to 30 carbon atoms, and examples thereof include methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, sec-butoxy, tert-butoxy, pentyloxy, isopentyloxy, neopentyloxy, hexyloxy, isohexyloxy, 1,1-dimethylbutoxy, 2,2-dimethylbutoxy, 3,3-dimethylbutoxy, 2-ethylbutoxy, heptyloxy, octyloxy, nonyloxy, decyloxy, undecyloxy, dodecyloxy, tridecyloxy, tetradecyloxy, hexadecyloxy, octadecyloxy, nonadecyloxy, eicosyloxy, docosyloxy, tricosyloxy, tetracosyloxy, pentacosyloxy, hexacosyloxy, heptacosyloxy, octacosyloxy, nonacosyloxy, and triacontyloxy.

[0050] In this specification, "C9-30 The term "alkoxy (group)" means a straight-chain or branched-chain alkoxy group having 9 to 30 carbon atoms, and examples thereof include nonyloxy, decyloxy, undecyloxy, dodecyloxy, tridecyloxy, tetradecyloxy, hexadecyloxy, octadecyloxy, nonadecyloxy, eicosyloxy, docosyloxy, tricosyloxy, tetracosyloxy, pentacosyloxy, hexacosyloxy, heptacosyloxy, octacosyloxy, nonacosyloxy, and triacontyloxy.

[0051] In this specification, "C 1-6 The term "alkoxy (group)" refers to a straight-chain or branched-chain alkoxy group having 1 to 6 carbon atoms, and examples thereof include methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, sec-butoxy, tert-butoxy, pentyloxy, isopentyloxy, neopentyloxy, and hexyloxy. 1-4 Alkoxy groups are preferred.

[0052] As used herein, "HaloC 1-6 The alkoxy group is defined as the above-mentioned "C 1-6 It means a group in which one or more hydrogen atoms in the "alkoxy" group are substituted with a halogen atom. Specific examples include difluoromethoxy, trifluoromethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, pentafluoroethoxy, 2,2,3,3,3-pentafluoropropoxy, 2,2,3,3-tetrafluoropropoxy, 3,3,3-trifluoropropoxy, 4,4,4-trifluorobutoxy, 5,5,5-trifluoropentyloxy, 6,6,6-trifluorohexyloxy, and the like. Among them, "haloC 1-4 Alkoxy is preferred.

[0053] As used herein, "fluoro C 1-6 The term "alkoxy (group)" refers to the above-mentioned "halo C 1-6The term "alkoxy" refers to a group in which the halogen atom in the "alkoxy" group is a fluorine atom. Specific examples include difluoromethoxy, trifluoromethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, pentafluoroethoxy, 2,2,3,3-tetrafluoropropoxy, 3,3,3-trifluoropropoxy, 4,4,4-trifluorobutoxy, 5,5,5-trifluoropentyloxy, and 6,6,6-trifluorohexyloxy. Among these, "fluoro C" such as difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, pentafluoroethoxy, 2,2,3,3,3-pentafluoropropoxy, 2,2,3,3-tetrafluoropropoxy, 3,3,3-trifluoropropoxy, and 4,4,4-trifluorobutoxy are particularly preferred. 1-4 Alkoxy (group) is preferred, with difluoromethoxy, trifluoromethoxy, 2,2,2-trifluoroethoxy, pentafluoroethoxy or pentafluoroethoxy being more preferred, and trifluoromethoxy being particularly preferred.

[0054] In the present specification, the term "aryl (group)" refers to a monocyclic or polycyclic (condensed) hydrocarbon group exhibiting aromaticity, and specifically includes, for example, C aryl groups such as phenyl, 1-naphthyl, 2-naphthyl, 2-biphenylyl, 3-biphenylyl, 4-biphenylyl, 1-anthryl, 2-anthryl, 9-anthryl, 3-phenanthryl, and 9-phenanthryl. 6-14 Among them, phenyl, 1-naphthyl and 2-naphthyl are preferred.

[0055] In the present specification, the term "nitrogen-containing aromatic heterocyclic compound" refers to a monocyclic or condensed polycyclic aromatic heterocyclic compound containing, as ring-constituting atoms other than carbon atoms, 1 to 4 heteroatoms selected from a nitrogen atom, a sulfur atom and an oxygen atom, and containing at least one nitrogen atom as a ring-constituting atom. Preferable examples of the "nitrogen-containing aromatic heterocyclic compound" include 5- or 6-membered monocyclic nitrogen-containing aromatic heterocyclic compounds such as pyrrole, imidazole, pyrazole, thiazole, isothiazole, oxazole, isoxazole, pyridine, pyrazine, pyrimidine, pyridazine, 1,2,4-oxadiazole, 1,3,4-oxadiazole, 1,2,4-thiadiazole, 1,3,4-thiadiazole, triazole, tetrazole, and triazine; benzimidazole, benzoxazole, benzisoxazole, benzothiazole, benzisothiazole, benzotriazole, imidazopyridine, thienopyridine, furopyridine, pyrrolopyridine, pyrazolopyridine, oxazolopyridine, and the like. Examples of the nitrogen-containing aromatic heterocyclic compound include 8- to 14-membered condensed polycyclic (preferably bicyclic or tricyclic) nitrogen-containing aromatic heterocyclic compounds such as quinidine, thiazolopyridine, imidazopyrazine, imidazopyrimidine, thienopyrimidine, furopyrimidine, pyrrolopyrimidine, pyrazolopyrimidine, oxazolopyrimidine, thiazolopyrimidine, pyrazolotriazine, indole, isoindole, 1H-indazole, purine, isoquinoline, quinoline, phthalazine, naphthyridine, quinoxaline, quinazoline, cinnoline, carbazole, β-carboline, phenanthridine, acridine, phenazine, phenothiazine, and phenoxazine, and a 5- or 6-membered monocyclic nitrogen-containing aromatic heterocyclic compound or a bicyclic nitrogen-containing aromatic heterocyclic compound is preferred. As the 5- or 6-membered monocyclic nitrogen-containing aromatic heterocyclic compound, pyridine or imidazole is more preferred, and as the bicyclic nitrogen-containing aromatic heterocyclic compound, benzimidazole is more preferred, with pyridine or imidazole being particularly preferred.

[0056] In the present specification, the term "optionally substituted" means unsubstituted or having one or more substituents, and unless otherwise specified, the "substituents" include (1) a halogen atom, (2) a nitro group, (3) a cyano group, (4) a C 1-30 Alkyl group, (5) haloC 1-6 Alkyl group, (6) C 3-8 Cycloalkyl groups, (7) C 1-30 Alkoxy group, (8) haloC 1-6 Alkoxy group, (9) C 6-14Among them, halogen atoms, cyano groups, C 1-6 Alkyl group, haloC 1-6 Alkyl group, C 1-6 Alkoxy group, haloC 1-6 An alkoxy group or a phenyl group is preferred, a halogen atom (e.g., a fluorine atom), C 1-6 Alkyl groups (e.g., methyl, ethyl), C 1-6 Alkoxy group (e.g., methoxy, ethoxy) or haloC 1-6 More preferred are alkyl groups (e.g., trifluoromethyl). When multiple substituents are present, each of the substituents may be the same or different. The above substituents may each further comprise one or more of C 1-6 Alkyl group, C 1-6 It may be substituted with an alkoxy group, a halogen atom, a phenyl group, or the like.

[0057] In the present specification, the term "hydrocarbon solvent" refers to solvents including aromatic hydrocarbon solvents and / or aliphatic hydrocarbon solvents. Among them, aliphatic hydrocarbon solvents are preferred from the viewpoints of odor and toxicity.

[0058] In the present specification, examples of the "aromatic hydrocarbon solvent" include benzene, toluene, xylene, etc.

[0059] In the present specification, examples of the "aliphatic hydrocarbon solvent" include n-hexane, isohexane, n-heptane, n-octane, cyclohexane, methylcyclohexane, and mixed solvents thereof.

[0060] In this specification, "soluble in a hydrocarbon solvent (or an aliphatic hydrocarbon solvent)" means that in a solution of the composition of the present invention and a hydrocarbon solvent (or an aliphatic hydrocarbon solvent) at 25° C., the composition of the present invention dissolves at a concentration of 5% by weight or more to form a transparent homogeneous solution. In addition, "easily soluble in a hydrocarbon solvent (or an aliphatic hydrocarbon solvent)" means that in a solution of the composition of the present invention and a hydrocarbon solvent (or an aliphatic hydrocarbon solvent) at 25° C., the composition of the present invention dissolves at a concentration of 20% by weight or more (preferably 30% by weight or more) to form a transparent homogeneous solution.

[0061] (Composition of the present invention) The composition of the present invention will now be described.

[0062] The composition of the present invention comprises (I) a base A, or The following formula (5):

[0063] [ka]

[0064] [In the formula, R and R′ each independently represent an optionally substituted C 1-30 Alkyl groups, optionally substituted C 3-15 Cycloalkyl group or optionally substituted C 6-14 represents an aryl group. Compounds having a total of 8 or more carbon atoms, (II) Formula (1):

[0065] [ka]

[0066] [In the formula, R 1 , R 2 , R 3 and R 4 Each independently represents one or more fluorine atoms or fluoro C 1-4 Alkyl-substituted C 6-14 represents an aryl group, and [AH] + represents a cation derived from base A. Here, the base A is (i) Two or more identical or different C 1-30 Alkyl group or C 1-30 Nitrogen-containing aromatic heterocyclic compounds having a total of 25 or more carbon atoms substituted with an alkoxy group, or (ii) Formula (2):

[0067] [ka]

[0068] (Wherein, Ar is optionally substituted C 6-14 represents an aryl group, and R 5 and R 6 each independently represents an optionally substituted C 1-30 represents an alkyl group; and represents an aromatic amine compound having a total of 25 or more carbon atoms. The composition contains a compound represented by the formula:

[0069] Preferred embodiments of the base A are described below. The nitrogen-containing aromatic heterocyclic compound (i) of the base A may be the same or different, and may have two, C 9-30 Alkyl group or C 9-30 Preferred are 5- or 6-membered monocyclic nitrogen-containing aromatic heterocyclic compounds substituted with an alkoxy group (e.g., pyrrole, imidazole, pyrazole, thiazole, isothiazole, oxazole, isoxazole, pyridine, pyrazine, pyrimidine, pyridazine, 1,2,4-oxadiazole, 1,3,4-oxadiazole, 1,2,4-thiadiazole, 1,3,4-thiadiazole, triazole, tetrazole, triazine, etc.), and the same or different two, C 14-30 Alkyl group or C 14-30 More preferred are pyridine or imidazole substituted with an alkoxy group. The nitrogen-containing aromatic heterocyclic compound preferably has a total of 25 or more carbon atoms, more preferably 30 or more carbon atoms, and even more preferably 35 or more carbon atoms.

[0070] Preferred specific examples of the nitrogen-containing aromatic heterocyclic compound as the base A include, for example, 2,5-dinonadecylpyridine, 2,6-dinonadecylpyridine, 2-nonadecyl-5-octadecylpyridine, 2-nonadecyl-4-octadecyloxypyridine, 2-nonadecyl-6-octadecyloxypyridine, 4-nonadecyl-1-octadecylimidazole, 5-nonadecyl-1-octadecylimidazole, and 2-nonadecyl-1-octadecylimidazole.

[0071] Another preferred nitrogen-containing aromatic heterocyclic compound of the base A (i) is a compound having two identical or different nitrogen-containing aromatic heterocyclic rings, 9-30 Alkyl group or C 9-30 and bicyclic nitrogen-containing aromatic heterocyclic compounds substituted with an alkoxy group (e.g., benzimidazole, benzoxazole, benzisoxazole, benzothiazole, benzisothiazole, benzotriazole, imidazopyridine, thienopyridine, furopyridine, pyrrolopyridine, pyrazolopyridine, oxazolopyridine, thiazolopyridine, imidazopyrazine, imidazopyrimidine, thienopyrimidine, furopyrimidine, pyrrolopyrimidine, pyrazolopyrimidine, oxazolopyrimidine, thiazolopyrimidine, pyrazolotriazine, indole, isoindole, 1H-indazole, purine, isoquinoline, quinoline, phthalazine, naphthyridine, quinoxaline, quinazoline, cinnoline, etc.). 9-30 Alkyl group or C 9-30 Alkoxy groups (more preferably C 14-30 Alkyl group or C 14-30 Benzimidazole substituted with an alkoxy group is more preferred. The nitrogen-containing aromatic heterocyclic compound preferably has a total of 25 or more carbon atoms, more preferably 30 or more carbon atoms, and even more preferably 35 or more carbon atoms.

[0072] Other preferred specific examples of the nitrogen-containing aromatic heterocyclic compound as the base A include, for example, 2,6-dinonadecylbenzimidazole, 1,2-dioctadecylbenzimidazole, 1,2-diheptadecylbenzimidazole, 2-heptadecyl-1-octadecylbenzimidazole, and 1-heptadecyl-2-octadecylbenzimidazole.

[0073] The aromatic amine compound represented by formula (2) of base A (ii) (hereinafter also referred to as "compound (2)") is Ar in the formula (2) is preferably a halogen atom, a cyano group, C 1-30 Alkyl group, haloC 1-6 Alkyl group, C 1-30 Alkoxy groups and haloC 1-6 C, which may be substituted with a substituent selected from the group consisting of alkoxy groups 6-14 An aryl group, more preferably a halogen atom, C 1-30 Alkyl group, C 1-30 Alkoxy and haloC 1-6 Ar is a phenyl group, a 1-naphthyl group, or a 2-naphthyl group (particularly preferably a phenyl group) which may be substituted with a substituent selected from the group consisting of alkyl groups. In addition, another preferred embodiment of Ar is a halogen atom, C 1-6 Alkyl group, C 1-6 Alkoxy and haloC 1-6 It is a phenyl group which may be substituted with a substituent selected from the group consisting of alkyl groups. The total number of carbon atoms in compound (2) is preferably 30 or more, and more preferably 35 or more.

[0074] R in the above formula (2) 5 and R 6 are preferably each independently optionally substituted with a halogen atom (e.g., a fluorine atom). 1-30 More preferably, each independently is an alkyl group, C 1-30 is an alkyl group, more preferably C 9-30 alkyl group, and particularly preferably the same C 14-30It is an alkyl group.

[0075] Suitable compounds (2) include the following compounds: [Compound (2-1)] In the formula (2), Ar is a halogen atom, a cyano group, or C 1-30 Alkyl group, haloC 1-6 Alkyl group, C 1-30 Alkoxy groups and haloC 1-6 C, which may be substituted with a substituent selected from the group consisting of alkoxy groups 6-14 is an aryl group, R 5 and R 6 each independently represents a C which may be substituted with a halogen atom (e.g., a fluorine atom); 1-30 is an alkyl group, and Compound (2) having a total carbon number of 25 or more (preferably 30 or more).

[0076] [Compound (2-2)] In the formula (2), Ar is a halogen atom, C 1-30 Alkyl group, C 1-30 Alkoxy and haloC 1-6 a phenyl group, a 1-naphthyl group, or a 2-naphthyl group (preferably a phenyl group) optionally substituted with a substituent selected from the group consisting of alkyl groups; R 5 and R 6 However, each independently, C 1-30 is an alkyl group, and Compound (2), having a total carbon number of 35 or more.

[0077] [Compound (2-3)] In the formula (2), Ar is a phenyl group; R 5 and R 6 But the same C 14-30 is an alkyl group, and Compound (2), having a total carbon number of 35 or more.

[0078] Preferred specific examples of compound (2) include N,N-dihexadecylaniline, N,N-dioctadecylaniline, and N,N-didocosylaniline.

[0079] As the base A, a commercially available product may be used as it is, or a compound obtained by the production method shown below may be used.

[0080] (Method for producing base A (compound (2))) Compound (2) has the following formula:

[0081] [ka]

[0082] (In the formula, X represents a halogen atom, and the other symbols are the same as defined above.) As shown in the figure, in the presence of a base, aniline derivative (a1) and alkyl halide (R 5 -X and R 6 -X) in turn.

[0083] R 5 and R 6 When are the same group, compound (2) can be produced in one step from aniline derivative (a1).

[0084] Alkyl halide (R 5 -X or R 6 The amount of -X) used is 1 to 2 moles (preferably 1 to 1.2 moles) per mole of the aniline derivative ((a1) or (a2)). R 5 and R 6 are the same group, the amount of the alkyl halide used is 2 to 4 mol (preferably 2 to 3 mol) per 1 mol of the aniline derivative (a1). The reaction solvent is not particularly limited, but for example, ether solvents such as tetrahydrofuran, diethoxyethane, etc., toluene, dimethylformamide, dimethylsulfoxide, etc. are preferable. Examples of the base include sodium hydride, potassium carbonate, potassium tert-butoxide, etc. The amount of the base used is 1 to 2 mol (preferably 1 to 1.2 mol) per 1 mol of the aniline derivative ((a1) or (a2)). The reaction temperature is preferably from room temperature to 180°C. The reaction time is usually from 1 hour to 48 hours.

[0085] (Base A (two or more identical or different, C 1-30 Alkyl group or C 1-30 A method for producing a nitrogen-containing aromatic heterocyclic compound having a total of 25 or more carbon atoms and substituted with an alkoxy group The nitrogen-containing aromatic heterocyclic compound having a total carbon number of 25 or more is represented by the following formula:

[0086] [ka]

[0087] (In the formula:

[0088] [ka]

[0089] represents a nitrogen-containing aromatic heterocyclic group, X' represents a halogen atom, R 7 is optionally substituted C 1-30 represents an alkyl group, and n1 represents an integer of 2 or more.) is reacted with compound (a3) ​​in a solvent that does not affect the reaction in the presence of a base, and a phosphonium salt (R 7 -CH2PPh3X') to obtain compound (a4) (Step 1), which can be reacted with a reducing agent to produce base (A2) (Step 2).

[0090] In the above step 1, examples of the base used include sodium hydride, potassium carbonate, potassium tert-butoxide, and the like. The amount of the base used is 1 to 2 moles (preferably 1 to 1.2 moles) relative to the equivalent (1 mole) of the formyl group of compound (a3). The phosphonium salt (R 7 The amount of --CH2PPh3X') used is also 1 to 2 moles (preferably 1 to 1.2 moles) relative to the equivalent (1 mole) of the formyl group of compound (a3). The reaction solvent in step 1 is not particularly limited, but for example, ether solvents such as tetrahydrofuran, diethoxyethane, etc., aromatic hydrocarbon solvents such as toluene, etc., aliphatic hydrocarbon solvents such as hexane, dimethylformamide, dimethylsulfoxide, etc. are preferred. The reaction temperature in step 1 is preferably from room temperature to 180°C. The reaction time in step 1 is usually from 0.5 to 48 hours.

[0091] In the step 2, for example, hydrogen, ammonium formate, ammonium chloride, etc. can be used as a reducing agent in the presence of a metal catalyst. As the metal catalyst, a transition metal catalyst such as Pd / C, Pt / C, etc. is preferable. The amount of the metal catalyst used is 0.001 to 1.0 mol (preferably 0.01 to 0.5 mol) relative to 1 mol of the double bond in compound (a4). The reaction solvent in step 2 is not particularly limited, but for example, hexane, toluene, tetrahydrofuran, ethanol, etc. are preferable, and a mixture of these solvents may also be used. The conditions for the reduction reaction in step 2 may be appropriately selected from normal pressure, medium pressure, and the like, depending on the progress of the reaction. The reaction temperature in step 2 is preferably from room temperature to 180°C. The reaction time in step 2 is usually from 1 hour to 72 hours.

[0092] A preferred embodiment of the compound represented by the formula (5) (hereinafter, also referred to as "compound (5)") will be described below.

[0093] Each group in compound (5) will be described below.

[0094] The total number of carbon atoms in R and R' is 8 or more, and preferably 16 or more. The total number of carbon atoms in R and R' may be 20 or more, 25 or more, or 28 or more. In addition, the total number of carbon atoms in R and R' is preferably 32 or less. R and R′ are each independently an optionally substituted C 1-30 Alkyl groups, optionally substituted C 3-15 Cycloalkyl group or optionally substituted C 6-14 are each independently an aryl group, (1) a halogen atom, (2) C 1-30 Alkoxy groups and (3) Haro C 1-30 Alkoxy group C, which may be substituted with a substituent selected from the group consisting of 1-30 Alkyl groups; (1) a halogen atom, (2) C 1-30 Alkyl groups, (3) C 1-30 Alkoxy groups, (4) HaroC 1-30 Alkyl groups and (5) Haro C 1-30 Alkoxy group C, which may be substituted with a substituent selected from the group consisting of 3-15 a cycloalkyl group; or (1) a halogen atom, (2) C 1-30 Alkyl groups, (3) C 1-30 Alkoxy groups, (4) HaroC 1-30 Alkyl groups and (5) Haro C 1-30 Alkoxy group C, which may be substituted with a substituent selected from the group consisting of 6-14 Aryl Group and more preferably, each independently is C 1-30 Alkyl group; C3-8 Cycloalkyl groups (e.g., cyclopentyl, cyclohexyl, etc.); or (1) a halogen atom, (2) C 1-6 Alkyl groups, (3) C 1-6 Alkoxy groups, (4) HaroC 1-6 Alkyl groups and (5) Haro C 1-6 Alkoxy group and more preferably each independently is a phenyl group optionally substituted with a substituent selected from the group consisting of 1-30 Alkyl groups (preferably C 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 4 1-18 alkyl group), and particularly preferably each independently represents 14-30 It is an alkyl group.

[0095] Suitable compounds (5) include the following compounds:

[0096] [Compound (5-1)] In the formula (5), R and R' are each independently C 1-30 is an alkyl group, and The total number of carbon atoms in R and R' is 8 or more. Compound (5).

[0097] [Compound (5-2)] In the formula (5), R and R' are each independently C 1-30 is an alkyl group, and The total number of carbon atoms in R and R' is 10 or more. Compound (5).

[0098] [Compound (5-3)] In the formula (5), R and R' are each independently (1) a halogen atom, (2) C 1-30 Alkoxy groups and (3) Haro C 1-30 Alkoxy group C, which may be substituted with a substituent selected from the group consisting of 1-30 Alkyl groups; (1) a halogen atom, (2) C 1-30 Alkyl groups, (3) C 1-30 Alkoxy groups, (4) HaroC 1-30 Alkyl groups and (5) Haro C 1-30 Alkoxy group C, which may be substituted with a substituent selected from the group consisting of 3-15 a cycloalkyl group; or (1) a halogen atom, (2) C 1-30 Alkyl groups, (3) C 1-30 Alkoxy groups, (4) HaroC 1-30 Alkyl groups and (5) Haro C 1-30 Alkoxy group C, which may be substituted with a substituent selected from the group consisting of 6-14 Aryl Group and The total number of carbon atoms in R and R' is 16 or more. Compound (5).

[0099] [Compound (5-4)] In the formula (5), R and R' are each independently C 1-30 an alkyl group, or (1) a halogen atom, (2) C 1-30 Alkyl groups, (3) C 1-30 Alkoxy groups, (4) HaroC 1-30 Alkyl groups and (5) Haro C 1-30 Alkoxy group C, which may be substituted with a substituent selected from the group consisting of 6-14 Aryl Group and The total number of carbon atoms in R and R' is 16 or more. Compound (5).

[0100] [Compound (5-5)] In the formula (5), R and R' are each independently C 1-30 Alkyl groups, C 3-8 a cycloalkyl group (e.g., cyclopentyl, cyclohexyl, etc.), or (1) a halogen atom, (2) C 1-6 Alkyl groups, (3) C 1-6 Alkoxy groups, (4) HaroC 1-6 Alkyl groups and (5) Haro C 1-6 Alkoxy group A phenyl group which may be substituted with a substituent selected from the group consisting of and The total number of carbon atoms in R and R' is 16 or more. Compound (5).

[0101] [Compound (5-6)] In the formula (5), R and R' are each independently C 1-30 is an alkyl group, and The total number of carbon atoms in R and R' is 16 or more. Compound (5).

[0102] Preferred specific examples of compound (5) include dibutyl ether, dihexyl ether, dioctyl ether, didecyl ether, didodecyl ether, ditetradecyl ether, dihexadecyl ether, dioctadecyl ether, docosyl ethyl ether, tetradecyloxyethyl tetradecyl ether, cyclopentyl methyl ether, diphenyl ether, and octadecyl phenyl ether. Among these, R and R′ in dibutyl ether, dihexyl ether, dioctyl ether, didecyl ether, didodecyl ether, ditetradecyl ether, dihexadecyl ether, dioctadecyl ether, dinodecyl ether, and the like, each independently represent C 1-30 Compound (5) is more preferred, in which R and R' are alkyl groups and the total number of carbon atoms of R and R' is 8 or more. 14-30 Compound (5), which is an alkyl group and has a total carbon number of 16 or more and 32 or less, is more preferred.

[0103] Compound (5) in which the total number of carbon atoms in R and R′ is 7 or less is not preferred because it has a low boiling point, which may make it difficult to industrially control the content, and it may act as a catalyst poison.

[0104] Preferred embodiments of the compound represented by formula (1) (hereinafter also referred to as "compound (1)") will be described below.

[0105] Each group in compound (1) will be explained below.

[0106] R 1 , R 2 , R 3 and R 4 are preferably each independently one or more fluorine atoms or fluoro C 1-4R is a phenyl group, a 1-naphthyl group, a 2-naphthyl group, a 2-biphenylyl group, a 3-biphenylyl group, a 4-biphenylyl group, a 1-anthryl group, a 2-anthryl group, a 9-anthryl group, a 3-phenanthryl group, or a 9-phenanthryl group, each of which is independently substituted with one or more fluorine atoms or trifluoromethyl groups, and particularly preferably R 1 , R 2 , R 3 and R 4 are all identical to each other, a pentafluorophenyl group, a 2,2',3,3',4',5,5',6,6'-nonafluoro-4-(1,1'-biphenylyl) group, a 2,3,4,5,6,7,8-heptafluoro-1-naphthyl group, or a 1,3,4,5,6,7,8-heptafluoro-2-naphthyl group.

[0107] [AH] is a cation derived from base A. + The preferred embodiments of A in the formula (I) are the same as those described above.

[0108] Suitable compounds (1) include the following compounds: [Compound (1-1)] In the formula (1), R 1 , R 2 , R 3 and R 4 each independently represents one or more fluorine atoms or fluoro C 1-4 a phenyl group, a 1-naphthyl group, a 2-naphthyl group, a 2-biphenylyl group, a 3-biphenylyl group, a 4-biphenylyl group, a 1-anthryl group, a 2-anthryl group, a 9-anthryl group, a 3-phenanthryl group, or a 9-phenanthryl group substituted by an alkyl group (e.g., a trifluoromethyl group); A is represented by the formula (2), Ar is a halogen atom, a cyano group, or C 1-30 Alkyl group, haloC 1-6 Alkyl group, C 1-30 Alkoxy groups and haloC 1-6C, which may be substituted with a substituent selected from the group consisting of alkoxy groups 6-14 is an aryl group, R 5 and R 6 each independently represents a C which may be substituted with a halogen atom (e.g., a fluorine atom); 1-30 is an alkyl group, and Compound (1), having a total carbon number of 25 or more (preferably 30 or more).

[0109] [Compound (1-2)] In the formula (1), R 1 , R 2 , R 3 and R 4 are each independently a phenyl group, a 1-naphthyl group or a 2-naphthyl group substituted by one or more fluorine atoms or trifluoromethyl groups, A is represented by the formula (2), Ar is a halogen atom, C 1-30 Alkyl group, C 1-30 Alkoxy and haloC 1-6 a phenyl group, a 1-naphthyl group, or a 2-naphthyl group (preferably a phenyl group) optionally substituted with a substituent selected from the group consisting of alkyl groups; R 5 and R 6 However, each independently, C 1-30 is an alkyl group, and Compound (1), having a total carbon number of 35 or more.

[0110] [Compound (1-3)] In the formula (1), R 1 , R 2 , R 3 and R 4 are all identical to each other, a pentafluorophenyl group, a 2,2',3,3',4',5,5',6,6'-nonafluoro-4-(1,1'-biphenylyl) group, a 2,3,4,5,6,7,8-heptafluoro-1-naphthyl group, or a 1,3,4,5,6,7,8-heptafluoro-2-naphthyl group, A is represented by the formula (2), Ar is a phenyl group; R 5 and R 6 But the same C 14-30 is an alkyl group, and Compound (1), having a total carbon number of 35 or more.

[0111] [Compound (1-4)] In the formula (1), R 1 , R 2 , R 3 and R 4 each independently represents one or more fluorine atoms or fluoro C 1-4 a phenyl group, a 1-naphthyl group, a 2-naphthyl group, a 2-biphenylyl group, a 3-biphenylyl group, a 4-biphenylyl group, a 1-anthryl group, a 2-anthryl group, a 9-anthryl group, a 3-phenanthryl group, or a 9-phenanthryl group substituted by an alkyl group (e.g., a trifluoromethyl group); A is two or more identical or different C 9-30 Alkyl group or C 9-30 a 5- or 6-membered monocyclic nitrogen-containing aromatic heterocyclic compound substituted by an alkoxy group (e.g., pyrrole, imidazole, pyrazole, thiazole, isothiazole, oxazole, isoxazole, pyridine, pyrazine, pyrimidine, pyridazine, 1,2,4-oxadiazole, 1,3,4-oxadiazole, 1,2,4-thiadiazole, 1,3,4-thiadiazole, triazole, tetrazole, triazine, etc.), and Compound (1), having a total carbon number of 25 or more (preferably 30 or more).

[0112] [Compound (1-5)] In the formula (1), R 1 , R 2 , R 3 and R 4 are each independently a phenyl group, a 1-naphthyl group or a 2-naphthyl group substituted by one or more fluorine atoms or trifluoromethyl groups, A is two identical or different C 14-30 Alkyl group or C 14-30 pyridine or imidazole substituted with an alkoxy group (preferably 2,5-dinonadecylpyridine, 2,6-dinonadecylpyridine, 2-nonadecyl-5-octadecylpyridine, 2-nonadecyl-4-octadecyloxypyridine, 2-nonadecyl-6-octadecyloxypyridine, 4-nonadecyl-1-octadecylimidazole, 5-nonadecyl-1-octadecylimidazole, or 2-nonadecyl-1-octadecylimidazole), and Compound (1), having a total carbon number of 35 or more.

[0113] [Compound (1-6)] In the formula (1), R 1 , R 2 , R 3 and R 4 are all identical to each other, a pentafluorophenyl group, a 2,2',3,3',4',5,5',6,6'-nonafluoro-4-(1,1'-biphenylyl) group, a 2,3,4,5,6,7,8-heptafluoro-1-naphthyl group, or a 1,3,4,5,6,7,8-heptafluoro-2-naphthyl group (preferably a pentafluorophenyl group), A is two identical or different C 14-30 Alkyl group or C 14-30 an alkoxy-substituted pyridine (preferably 2,5-dinonadecylpyridine, 2,6-dinonadecylpyridine, 2-nonadecyl-5-octadecylpyridine, 2-nonadecyl-4-octadecyloxypyridine or 2-nonadecyl-6-octadecyloxypyridine); and Compound (1), having a total carbon number of 35 or more.

[0114] [Compound (1-7)] In the formula (1), R 1 , R 2 , R 3 and R 4 each independently represents one or more fluorine atoms or fluoro C 1-4a phenyl group, a 1-naphthyl group, a 2-naphthyl group, a 2-biphenylyl group, a 3-biphenylyl group, a 4-biphenylyl group, a 1-anthryl group, a 2-anthryl group, a 9-anthryl group, a 3-phenanthryl group, or a 9-phenanthryl group substituted by an alkyl group (e.g., a trifluoromethyl group); A is two or more identical or different C 9-30 Alkyl group or C 9-30 a bicyclic nitrogen-containing aromatic heterocyclic compound substituted with an alkoxy group (e.g., benzimidazole, benzoxazole, benzisoxazole, benzothiazole, benzisothiazole, benzotriazole, imidazopyridine, thienopyridine, furopyridine, pyrrolopyridine, pyrazolopyridine, oxazolopyridine, thiazolopyridine, imidazopyrazine, imidazopyrimidine, thienopyrimidine, furopyrimidine, pyrrolopyrimidine, pyrazolopyrimidine, oxazolopyrimidine, thiazolopyrimidine, pyrazolotriazine, indole, isoindole, 1H-indazole, purine, isoquinoline, quinoline, phthalazine, naphthyridine, quinoxaline, quinazoline, cinnoline, etc.), and Compound (1), having a total carbon number of 25 or more (preferably 30 or more).

[0115] [Compound (1-8)] In the formula (1), R 1 , R 2 , R 3 and R 4 are each independently a phenyl group, a 1-naphthyl group or a 2-naphthyl group substituted by one or more fluorine atoms or trifluoromethyl groups, A is two identical or different C 14-30 Alkyl group or C 14-30 Benzimidazole substituted with an alkoxy group (preferably 2,6-dinonadecylbenzimidazole, 1,2-dioctadecylbenzimidazole, 1,2-diheptadecylbenzimidazole, 2-heptadecyl-1-octadecylbenzimidazole or 1-heptadecyl-2-octadecylbenzimidazole), and Compound (1), having a total carbon number of 35 or more.

[0116] [Compound (1-9)] In the formula (1), R 1 , R 2 , R 3 and R 4 are all identical to each other, a pentafluorophenyl group, a 2,2',3,3',4',5,5',6,6'-nonafluoro-4-(1,1'-biphenylyl) group, a 2,3,4,5,6,7,8-heptafluoro-1-naphthyl group, or a 1,3,4,5,6,7,8-heptafluoro-2-naphthyl group (preferably a pentafluorophenyl group), A is two identical or different C 14-30 Alkyl group or C 14-30 Benzimidazole substituted with an alkoxy group (preferably 2,6-dinonadecylbenzimidazole, 1,2-dioctadecylbenzimidazole, 1,2-diheptadecylbenzimidazole, 2-heptadecyl-1-octadecylbenzimidazole or 1-heptadecyl-2-octadecylbenzimidazole), and Compound (1), having a total carbon number of 35 or more.

[0117] Specific preferred examples of compound (1) include N,N-dioctadecylanilinium tetrakis(pentafluorophenyl)borate, 2,6-dinonadecylpyridinium tetrakis(pentafluorophenyl)borate, 2-nonadecyl-5-octadecyloxypyridinium tetrakis(pentafluorophenyl)borate, 4-nonadecyl-1-octadecylimidazolium tetrakis(pentafluorophenyl)borate, 5-nonadecyl-1-octadecylimidazolium tetrakis(pentafluorophenyl)borate, 2-nonadecyl-1-octadecylimidazolium tetrakis(pentafluorophenyl)borate, 1-heptadecyl-2-octadecylbenzimidazolium tetrakis(pentafluorophenyl)borate, and 2-heptadecyl-1-octadecylbenzimidazolium tetrakis(pentafluorophenyl)borate.

[0118] Other preferred specific examples of compound (1) include, for example, 2,6-dinonadecylbenzimidazolium tetrakis(pentafluorophenyl)borate, 1,2-dioctadecylbenzimidazolium tetrakis(pentafluorophenyl)borate, 1,2-diheptadecylbenzimidazolium tetrakis(pentafluorophenyl)borate, 2-heptadecyl-1-octadecylbenzimidazolium tetrakis(pentafluorophenyl)borate, 1-heptadecyl-2-octadecylbenzimidazolium tetrakis(pentafluorophenyl)borate, 2-heptadecyl-1-octadecylbenzimidazolium tetrakis(pentafluorophenyl)borate, and the like.

[0119] In the composition of the present invention, a base A and [AH] in compound (1) are + Preferably, the A's constituting the formula [AH] are the same. + Preferred embodiments of the above include cations in which a proton is added to each of the preferred embodiments of the base A.

[0120] In the composition of the present invention, the content of base A is usually 0.01 to 10 mol, preferably 0.01 to 2 mol, more preferably 0.01 to 1 mol, and particularly preferably 0.01 to 0.5 mol, relative to 1 mol of compound (1).

[0121] In the composition of the present invention, the blending ratio of compound (5) to compound (1) is not particularly limited. From the viewpoint of improving the solubility in aliphatic hydrocarbon solvents, the content of compound (5) is 0.1 mol or more, preferably in the range of 0.1 to 10 mol, and more preferably in the range of 0.1 to 3 mol, per 1 mol of compound (1).

[0122] The composition of the present invention is soluble in a hydrocarbon solvent at room temperature (15 to 30° C.). In addition, while conventionally known borate-type cocatalysts are insoluble in aliphatic hydrocarbon solvents such as n-hexane, the composition of the present invention exhibits good solubility in aliphatic hydrocarbon solvents, and is therefore useful as a cocatalyst for the polymerization reaction of homogeneous olefins or dienes.

[0123] (Method of producing the composition of the present invention) The method for producing the composition of the present invention (hereinafter also referred to as "the production method of the present invention") will be described below.

[0124] The composition of the present invention preferably does not contain a hydrogenated borate compound represented by formula (3) described below (e.g., hydrogenated tetrakis(pentafluorophenyl)borate), which can form a complex with an ether compound having a total carbon number of 7 or less and become a catalyst poison, or a metal salt of a tetra-substituted borate compound described below (e.g., lithium tetrakis(pentafluorophenyl)borate). In addition, the composition of the present invention preferably does not contain an ether compound having a total carbon number of 7 or less, which can become a catalyst poison. Not containing an ether compound having a total carbon number of 7 or less means: 1 This means that the results of H-NMR analysis show that no ether compounds with a total carbon number of 7 or less were detected.

[0125] The production method of the present invention (hereinafter also referred to as "Production method 1 of the present invention") comprises reacting a compound represented by the following formula (3):

[0126] [ka]

[0127] [R in the formula 1 , R 2 , R 3 and R 4 The definition of is the same as above.] The method includes a step of reacting a borate hydride compound represented by the following formula (3) with the base A, and is characterized in that more than 1 mole of base A is used per mole of compound (3).

[0128] In the above production method, examples of compound (3) used as a raw material include known compounds such as hydrogenated tetrakis(pentafluorophenyl)borate, hydrogenated tetrakis(nonafluoro[1,1'-biphenyl]-4-yl)borate, hydrogenated tetrakis(heptafluoro-2-naphthyl)borate, and hydrogenated [3,5-bis(trifluoromethyl)phenyl]borate.

[0129] The method for producing compound (3) is not particularly limited, but for example, a method for producing a compound represented by formula (4):

[0130] [ka]

[0131] [In the formula, R 1 , R 2 , R 3 and R 4 Each independently represents one or more fluorine atoms or fluoro C 1-4 Alkyl-substituted C 6-14 represents an aryl group, M represents an alkali metal such as lithium, potassium, or sodium, or an alkaline earth metal such as calcium, magnesium, or barium; and and n represents 1 or 2.] (hereinafter also referred to as "compound (4)") is treated with a protonic acid.

[0132] The compound (4) used in the production of the compound (3) may be a commercially available product or a purified product, or may be prepared by a method known per se (see, for example, Angew. Chem. Int. Ed., 2009, 48(40), 7444-7447).

[0133] The solvent used in the production of compound (3) is not particularly limited, but it is preferable to use ether solvents such as diethyl ether, tert-butyl methyl ether, cyclopentyl methyl ether, diisopropyl ether, etc., halogenated solvents such as dichloromethane, chloroform, etc., aromatic hydrocarbon solvents such as toluene, benzene, etc., aliphatic hydrocarbon solvents such as n-hexane, isohexane, n-heptane, octane, cyclohexane, methylcyclohexane, etc. These solvents may be used alone or in combination.

[0134] The protonic acid used in treating the compound (4) is not particularly limited, but examples thereof include hydrochloric acid, sulfuric acid, nitric acid, hydrobromic acid, and hydroiodic acid.

[0135] The amount of protonic acid used in the production of compound (3) is desirably 1 mole per mole of compound (4). When 1 mole or more of protonic acid is used, it is preferable to wash the organic phase with water until the pH of the aqueous phase after washing is 3 or more so that the protonic acid used does not remain in the organic phase after treatment. When the pH of the aqueous phase is less than 3, the protonic acid salt used remains in the organic phase, and in the reaction with base A, a protonic acid salt of base A is generated, and the protonic acid salt remains in the composition of the present invention, which may become a catalyst poison during polymerization.

[0136] In Production Method 1 of the present invention, the solution of compound (3) prepared as above can be used as is for the reaction with base A.

[0137] The base A used in the production method 1 of the present invention includes the above-mentioned compounds having a total carbon number of 25 or more (preferably 30 or more, more preferably 35 or more). Specific examples of the base A include nitrogen-containing aromatic heterocyclic compounds such as 2,5-dinonadecylpyridine, 2,6-dinonadecylpyridine, 2-nonadecyl-5-octadecylpyridine, 2-nonadecyl-4-octadecyloxypyridine, 2-nonadecyl-6-octadecyloxypyridine, 4-nonadecyl-1-octadecyl imidazole, 5-nonadecyl-1-octadecyl imidazole, and 2-nonadecyl-1-octadecyl imidazole; and aromatic amine compounds such as N,N-dihexadecylaniline, N,N-dioctadecylaniline, N,N-dinonadecylaniline, and N,N-didocosylaniline.

[0138] Among them, compound (3) and C 9-30 Alkyl groups (preferably C 14-30 Alkyl group) or C 9-30 Alkoxy groups (preferably C 14-30 The composition containing base A and compound (1) obtained by reacting with base A having two or more alkoxy groups is also soluble in an aliphatic hydrocarbon solvent.

[0139] In the production method 1 of the present invention, the base A is used in an amount exceeding 1 mole per mole of the compound (3). This can prevent the unreacted compound (3) from remaining in the product composition. The amount of the base A used per mole of the compound (3) is in the range of 1.01 to 5.0 moles, preferably in the range of 1.01 to 2.0 moles, and particularly preferably in the range of 1.01 to 1.5 moles. When the amount of the base A is 1.0 mole or less, an ether solvent (i.e., an ether compound) having a total carbon number of 7 or less or a compound (3) having water added thereto remains in the product composition, and when used as a polymerization cocatalyst, there is a concern that the ether compound having a total carbon number of 7 or less or the compound (3) having water added thereto may act as a catalyst poison. In addition, when the amount of the base A used is 1 mole per mole of the compound (3), the solubility of the composition of the present invention in an aliphatic hydrocarbon solvent decreases.

[0140] In Production Method 1 of the present invention, the reaction temperature and time are not particularly limited, but the reaction temperature is usually 10°C to 40°C, preferably 10°C to 35°C, and more preferably room temperature (15°C to 30°C), and the reaction time is 10 minutes or more.

[0141] After the reaction between compound (3) and base A is completed, the reaction solution is dehydrated with a drying agent such as anhydrous sodium sulfate or anhydrous magnesium sulfate, and then the solvent is removed to obtain a composition containing base A and compound (1).

[0142] Alternatively, after the reaction of compound (3) with base A is completed, a part of the reaction solvent can be distilled off, or solvent dilution and solvent distillation (solvent replacement) can be carried out once or multiple times to obtain a solution of a composition containing base A and compound (1).

[0143] A preferred embodiment of the compound (3) corresponds to a preferred embodiment of the anion moiety in the compound (1) (the anion moieties of the compounds (1-1) to (1-9)).

[0144] Suitable compounds (4) include the following compounds: [Compound (4-1)] In the formula (4), R 1 , R 2 , R 3 and R 4 each independently represents one or more fluorine atoms or fluoro C 1-4 a phenyl group, a 1-naphthyl group, a 2-naphthyl group, a 2-biphenylyl group, a 3-biphenylyl group, a 4-biphenylyl group, a 1-anthryl group, a 2-anthryl group, a 9-anthryl group, a 3-phenanthryl group, or a 9-phenanthryl group substituted by an alkyl group (e.g., a trifluoromethyl group); M is lithium, sodium, potassium, calcium, magnesium or barium; and Compound (4), wherein n is 1 or 2.

[0145] [Compound (4-2)] In the formula (4), R 1 , R 2 , R 3 and R 4 are each independently a phenyl group, a 1-naphthyl group or a 2-naphthyl group substituted by one or more fluorine atoms or trifluoromethyl groups, M is lithium, sodium or potassium; and Compound (4), wherein n is 1.

[0146] [Compound (4-3)] In the formula (4), R 1 , R 2 , R 3 and R 4 are all identical to each other, a pentafluorophenyl group, a 2,2',3,3',4',5,5',6,6'-nonafluoro-4-(1,1'-biphenylyl) group, a 2,3,4,5,6,7,8-heptafluoro-1-naphthyl group, or a 1,3,4,5,6,7,8-heptafluoro-2-naphthyl group, M is lithium or sodium, and Compound (4), wherein n is 1.

[0147] Preferred specific examples of compound (4) include lithium tetrakis(pentafluorophenyl)borate, sodium tetrakis(pentafluorophenyl)borate, lithium tetrakis(nonafluoro[1,1'-biphenyl]-4-yl)borate, lithium tetrakis(heptafluoro-2-naphthyl)borate, lithium [3,5-bis(trifluoromethyl)phenyl]borate, sodium [3,5-bis(trifluoromethyl)phenyl]borate, lithium tetrakis(2,3,4,5,6,7,8-heptafluoro-1-naphthyl)borate, lithium tetrakis(1,3,4,5,6,7,8-heptafluoro-2-naphthyl)borate, sodium tetrakis(2,3,4,5,6,7,8-heptafluoro-1-naphthyl)borate, and sodium Examples of known compounds include tetrakis(1,3,4,5,6,7,8-heptafluoro-2-naphthyl)borate.

[0148] Other preferred embodiments of the production method of the present invention include the following production methods (production method 2 and production method 3 of the present invention).

[0149] (Production Method 2 of the Present Invention) The composition of the present invention comprises a compound having the following formula:

[0150] [ka]

[0151] (The symbols in the formula are as defined above.) As shown in the above formula, the compound (4) can be produced by mixing and stirring a base A, a protonic acid, and the compound (4) in a solvent that does not affect the reaction, either sequentially or simultaneously in any order.

[0152] The amounts of base A, protonic acid and compound (4) used in Production Method 2 of the present invention, the reaction solvent, reaction temperature, reaction time and the like are similar to those in Production Method 1 of the present invention described above.

[0153] (Production Method 3 of the Present Invention) The composition of the present invention comprises a compound having the following formula:

[0154] [ka]

[0155] (The symbols in the formula are as defined above.) As shown in the above formula, 1 mole of base A, 1 mole of protonic acid, and compound (4) are mixed in any order or simultaneously relative to 1 mole of compound (4) in a solvent that does not affect the reaction, and the mixture is stirred, and then compound (5) is mixed therewith to produce the compound (5).

[0156] The amount of compound (5) used in Production Method 3 of the present invention is 0.1 mole or more, preferably 0.1 to 10 moles, and more preferably 0.1 to 3 moles, per mole of compound (1) (compound (4)). When the amount of compound (5) is less than 0.1 mole, the solubility of the composition of the present invention decreases. In addition, the types, amounts, reaction solvent, reaction temperature, reaction time, etc. of base A, protonic acid, and compound (4) used in Production Method 3 of the present invention are similar to those of Production Method 1 of the present invention described above.

[0157] The composition of the present invention contains base A or compound (5) and compound (1), is soluble (or easily soluble) in hydrocarbon solvents, particularly aliphatic hydrocarbon solvents, and does not contain compounds that can act as catalyst poisons, such as highly basic and nucleophilic amine compounds, proton acid salts of base A, and ether compounds having a total carbon number of 7 or less, and is therefore useful as a polymerization cocatalyst for olefins and dienes.

[0158] The present invention encompasses a method for producing a polymer, comprising polymerizing at least one monomer selected from the group consisting of olefins and dienes using the composition of the present invention as a cocatalyst. Polymerizing at least one monomer selected from the group consisting of olefins and dienes using a borate compound similar to compound (1) of the present invention as a cocatalyst is publicly known, for example as described in Patent Document 2. Therefore, the method for producing a polymer of the present invention can be carried out by referring to the method for producing a polymer described in Patent Document 2, except for using the composition of the present invention as a cocatalyst. EXAMPLES

[0159] The present invention will be specifically described with reference to the following Production Examples and Examples, but the present invention is not limited to these Production Examples and Examples. % indicates mol / mol% for yield, and % by weight for other items unless otherwise specified. In addition, room temperature indicates a temperature of 15°C to 30°C unless otherwise specified.

[0160] The following instruments were used for the analysis: 1 H-NMR and 19 F-NMR: 400YH manufactured by JEOL Ltd. (JEOL) Unless otherwise specified, the solvents and reagents used in the following examples were purchased from distributors such as Sigma-Aldrich, Tokyo Chemical Industry Co., Ltd., Fujifilm Wako Pure Chemical Industries, Ltd., Junsei Chemical Co., Ltd., Kanto Chemical Co., Ltd., and Combi-Blocks. Deuterated solvents used in NMR measurements were purchased from Cambridge Isotope Laboratory.

[0161] [Example 1] Compositions containing N,N-dioctadecylanilinium tetrakis(pentafluorophenyl)borate and N,N-dioctadecylaniline N,N-dioctadecylaniline (4.3g, 7.2mmol) and lithium tetrakis(pentafluorophenyl)borate triethyl ether complex (AGC Wakasa Chemical Co., Ltd.) (5.0g, 5.5mmol) were suspended in n-hexane (50mL), and then 1.0M hydrogen chloride-diethyl ether solution (5.5mL) was added dropwise and stirred at room temperature for 3 hours. The resulting suspension was filtered, and the filtrate was concentrated under reduced pressure at 50°C to obtain the title composition (7.31g). 1 H NMR (CDCl3) δ: 0.86-0.89 (6H, m), 1.17-1.48 (27H, m), 3.41 (4H, t), 7.23-7.26 (2H, m), 7.45-7.46 (3H, m); 19 F NMR (CDCl3) δ: -133.8 (8F, t), -163.4 (4F, t), -167.4 (8F, t).

[0162] It was confirmed that the composition obtained in Example 1 was soluble in n-hexane and cyclohexane at a concentration of 20% by weight.

[0163] [Example 2] Compositions containing N,N-dioctadecylanilinium tetrakis(pentafluorophenyl)borate and N,N-dioctadecylaniline N,N-dioctadecylanilinium tetrakis(pentafluorophenyl)borate (128mg, 0.1mmol) was added with n-hexane (512mg) and stirred (concentration 20wt%). N,N-dioctadecylanilinium tetrakis(pentafluorophenyl)borate (24mg, 0.04mmol) was added to the obtained two-layer separated solution and stirred to obtain a uniform n-hexane solution of a composition containing N,N-dioctadecylanilinium tetrakis(pentafluorophenyl)borate and N,N-dioctadecylanilinium tetrakis(pentafluorophenyl)borate. The title composition was obtained by distilling off n-hexane under reduced pressure and drying at 50℃ under reduced pressure. 1H NMR (CDCl3) δ: 0.8 (6H, t), 1.10-1.50 (64H, m), 3.36-3.40 (4H, m), 7.10-7.12 (2H, m), 7.33-7.51 (3H, m); 19 F NMR (CDCl3) δ: -133.8 (8F, t), -163.4 (4F, t), -167.5 (8F, t).

[0164] It was confirmed that the composition obtained in Example 2 was soluble in n-hexane at a concentration of 20% by weight.

[0165] [Production Example 1] Synthesis of 2,6-bis(nonadecen-1-yl)pyridine To a mixture of pyridine-2,6-dicarboxaldehyde (1.0 g, 7.4 mmol), octadecyltriphenylphosphonium bromide (10 g, 17 mmol) and tetrahydrofuran (100 mL), potassium tert-butoxide (2.0 g, 18 mmol) was added at room temperature. The mixture was stirred at 60°C for 2 hours and allowed to cool to room temperature. The reaction mixture was carefully added to water and extracted with ethyl acetate. The organic phase was washed with a saturated saline solution, dried over anhydrous sodium sulfate, and the solvent was removed under reduced pressure. The resulting residue was suspended in diethyl ether, insoluble matter was filtered off, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane / ethyl acetate = 98 / 2 to 90 / 10) to obtain 2,6-bis(nonadecen-1-yl)pyridine (E / Z mixture; 3.9 g, 86%). 1 H NMR (CDCl3) δ: 0.88 (6H, t), 1.20-1.48 (60H, m), 2.56-2.62 (4H, m), 5.82-5.89(1H, m), 6.42-6.49 (2H, m), 7.04 (2H, d), 7.26-7.35 (1H, m), 7.53-7.57 (1H, m).

[0166] [Production Example 2] Synthesis of 2,6-di(nonadecyl)pyridine A mixture of 2,6-bis(nonadec-1-yl)pyridine (E / Z mixture; 3.5 g, 5.8 mmol) obtained in Production Example 1, 10% Pd / C (50% water content; 0.70 g) and tetrahydrofuran (100 mL) was stirred under a hydrogen atmosphere at room temperature and normal pressure for 15 hours. The mixture was filtered, and the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (n-hexane / ethyl acetate = 95 / 5) to obtain 2,6-di(nonadecyl)pyridine (3.0 g, 85%). 1 H NMR (CDCl3) δ: 0.88 (6H, t), 1.17-1.40 (64H, m), 1.65-1.70 (4H, m), 2.72-2.76 (4H, m), 6.93 (2H, d), 7.48 (1H, t).

[0167] [Production Example 3] Synthesis of 2,6-di(nonadecyl)pyridine hydrochloride A 1M hydrogen chloride-diethyl ether solution (10 mL) was added at room temperature to a n-hexane solution (30 mL) of 2,6-di(nonadecyl)pyridine (3.0 g, 4.9 mmol) obtained in Production Example 2, and the mixture was stirred for 1 hour. The resulting precipitate was collected by filtration, washed with n-hexane, and dried under reduced pressure to obtain 2,6-di(nonadecyl)pyridine hydrochloride (3.0 g, 94%). 1 H NMR (CDCl3) δ: 0.88 (6H, t), 1.24-1.45 (64H, m), 1.79-1.87 (4H, m), 3.32 (4H, br), 7.41 (2H, d), 8.08 (1H, br).

[0168] [Production Example 4] Synthesis of 2,6-di(nonadecyl)pyridinium tetrakis(pentafluorophenyl)borate 2,6-Di(nonadecyl)pyridine hydrochloride (0.50 g, 0.77 mmol) obtained in Production Example 3 and lithium tetrakis(pentafluorophenyl)borate diethyl ether complex (0.59 g, 0.78 mmol) were suspended in dichloromethane (20 mL) and stirred at room temperature for 1 hour. The resulting suspension was filtered, and the filtrate was concentrated under reduced pressure at 50° C. to obtain 2,6-di(nonadecyl)pyridinium tetrakis(pentafluorophenyl)borate (0.99 g, 99%). 1 H NMR (CDCl3) δ: 0.85-0.89 (6H, m), 1.23-1.35 (64H, m), 1.72-1.76 (4H, m), 2.94-2.98 (4H, t), 7.57 (2H, d), 8.27 (1H, dd); 19 F NMR (CDCl3) δ: -133.3 (8F, t), -163.2 (4F, t), -167.7 (8F, t).

[0169] [Example 3] Composition containing 2,6-di(nonadecyl)pyridinium tetrakis(pentafluorophenyl)borate and 2,6-di(nonadecyl)pyridine 2,6-Di(nonadecyl)pyridinium tetrakis(pentafluorophenyl)borate (129 mg, 0.1 mmol) obtained in Production Example 4 was added to 2,6-di(nonadecyl)pyridine (12.9 mg, 0.02 mmol) obtained in Production Example 2, and n-hexane (0.52 g) was further added and stirred for 1 hour to obtain a homogeneous n-hexane solution. The solvent was distilled off under reduced pressure to obtain the title composition. 1 H NMR (CDCl3) δ: 0.88 (6H, t), 1.20-1.50 (64H, m), 1.67-1.73 (4H, m), 2.88 (4H, t), 7.38 (2H, d), 8.03 (1H, dd); 19F NMR (CDCl3) δ: -133.9 (8F, t), -163.6 (4F, t), -167.7 (8F, t).

[0170] It was confirmed that the composition obtained in Example 3 was soluble in n-hexane at a concentration of 20% by weight.

[0171] [Production Example 5] Synthesis of 2-(nonadecen-1-yl)-5-octadecoxypyridine To a mixture of 5-octadecoxypyridine-2-carbaldehyde (2.0 g, 5.3 mmol), octadecyltriphenylphosphonium bromide (7.0 g, 12 mmol) and tetrahydrofuran (100 mL), potassium tert-butoxide (1.4 g, 12 mmol) was added at room temperature. The mixture was stirred at 60°C for 2 hours and allowed to cool to room temperature. The reaction mixture was carefully added to water and extracted with ethyl acetate. The organic phase was washed with a saturated saline solution, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The resulting residue was suspended in diethyl ether, insoluble matter was filtered off, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane / ethyl acetate = 98 / 2 to 90 / 10) to obtain 2-(nonadec-1-yl)-5-octadecoxypyridine (E / Z mixture; 3.1 g, 95%). 1 H NMR (CDCl3) δ: 0.87 (6H, t), 1.24-1.50 (60H, m), 1.76-1.80 (2H, m), 2.48-2.54 (2H, m), 3.95-4.00 (2H, m), 7.71-7.78 (1H, m), 6.36-6.40 (1H, m), 7.13-7.18 (2H, m), 8.2-8.27 (1H, m).

[0172] [Production Example 6] Synthesis of 2-nonadecyl-5-octadecoxypyridine A mixture of 2-(nonadec-1-yl)-5-octadecoxypyridine (E / Z mixture; 2.5 g, 4.1 mmol) obtained in Production Example 5, 10% Pd / C (50% water content; 0.70 g), n-hexane (100 mL) and tetrahydrofuran (100 mL) was stirred under a hydrogen atmosphere at room temperature and normal pressure for 15 hours. The reaction mixture was filtered, and the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (n-hexane / ethyl acetate = 95 / 5) to obtain 2-nonadecyl-5-octadecoxypyridine (1.0 g, 40%). 1 H NMR (CDCl3) δ: 0.87 (6H, t), 1.17-1.40 (64H, m), 1.42-1.76 (4H, m), 2.67-2.72 (2H, m), 3.95 (1H, t), 7.02 (2H, d), 7.10 (2H, dd), 8.19 (1H, d).

[0173] [Example 4] Composition containing 2-nonadecyl-5-octadecoxypyridinium tetrakis(pentafluorophenyl)borate and 2-nonadecyl-5-octadecoxypyridine 2-Nonadecyl-5-octadecoxypyridine (0.65g, 1.1mmol) obtained in Production Example 6 and lithium tetrakis(pentafluorophenyl)borate triethyl ether complex (0.80g, 0.88mmol) were suspended in cyclohexane (20mL), and then 1M hydrogen chloride-diethyl ether solution (0.88mL, 0.88mmol) was added and stirred at room temperature for 3 hours. Insoluble matter was removed by filtration, and the filtrate was dried under reduced pressure at 45°C to obtain the title composition. 1 H NMR (CDCl3) δ: 0.88 (3H, t), 1.22-1.44 (64H, m), 1.69-1.86 (4H, m), 2.93 (2H, t), 4.02 (2H, t), 7.60 (1H, d), 7.84 (1H, dd), 7.90 (1H, d).

[0174] It was confirmed that the composition obtained in Example 4 was soluble in n-hexane at a concentration of 20% by weight.

[0175] [Production Example 7] Synthesis of 1-octadecylimidazole-2-carbaldehyde A mixture of 1H-imidazole-2-carbaldehyde (2.0 g, 21 mmol), 1-bromooctadecane (7.5 g, 22 mmol), potassium carbonate (4.5 g, 33 mmol) and N,N-dimethylformamide was stirred at room temperature for 15 hours. The mixture was poured into water and extracted with ethyl acetate. The organic phase was dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel chromatography (n-hexane-ethyl acetate = 98 / 2 to 90 / 10) to obtain 1-octadecylimidazole-2-carbaldehyde (6.45 g, 89%). 1 H NMR (CDCl3) δ: 0.88 (3H, t), 1.24-1.30 (34H, m), 1.75-1.79 (2H, m), 4.36-4.40 (2H, m), 7.15 (1H, s), 7.29 (1H, d), 9.81 (1H, s).

[0176] [Production Example 8] Synthesis of 2-(nonadecen-1-yl)-1-octadecylimidazole To a mixture of 1-octadecylimidazole-2-carbaldehyde (5.0 g, 14 mmol), octadecyltriphenylphosphonium bromide (10 g, 16.8 mmol) and tetrahydrofuran (50 mL) obtained in Production Example 7, potassium tert-butoxide (2.0 g, 17.8 mmol) was added at room temperature. The mixture was stirred at 60°C for 2 hours and allowed to cool to room temperature. The reaction mixture was carefully added to water and extracted with ethyl acetate. The organic phase was washed with a saturated saline solution, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The obtained residue was suspended in diethyl ether, insoluble matter was filtered off, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography (n-hexane / ethyl acetate = 98 / 2 to 90 / 10) to obtain 2-(nonadecen-1-yl)-1-octadecylimidazole (E / Z mixture; 7.5 g, 89%). 1 H NMR (CDCl3) δ: 0.88 (6H, t), 1.11-1.73 (64H, m), 2.20-2.26 (2H, m), 3.85-3.90 (2H, m), 6.11-6.23 (1H, m), 6.67-6.74 (1H, m), 6.81-6.82 (1H, m), 6.98-7.09 (1H, m).

[0177] [Production Example 9] Synthesis of 2-nonadecyl-1-octadecylimidazole A mixture of 2-(nonadecen-1-yl)-1-octadecylimidazole (E / Z mixture; 1.5 g, 2.6 mmol) obtained in Production Example 8, 10% Pd / C (50% water content; 0.30 g) and tetrahydrofuran (100 mL) was stirred under a hydrogen atmosphere at room temperature and normal pressure for 15 hours. The mixture was filtered, and the filtrate was concentrated under reduced pressure. The obtained residue was purified by silica gel column chromatography (n-hexane / ethyl acetate = 95 / 5) to obtain 2-nonadecyl-1-octadecylimidazole (1.0 g, 67%). 1H NMR (CDCl3) δ: 0.88 (6H, t), 1.25-1.75 (66H, m), 2.60-2.64 (2H, m), 3.79-3.82 (2H, m), 6.79 (1H, d), 6.93 (1H, d).

[0178] [Production Example 10] Synthesis of 2-nonadecyl-1-octadecylimidazole hydrochloride To a suspension of 2-nonadecyl-1-octadecylimidazole (0.88 g, 1.5 mmol) obtained in Production Example 9 and n-hexane (100 mL), 1 M hydrogen chloride-diethyl ether solution (10 mL) was added at room temperature and stirred for 1 hour. The solvent of the obtained suspension was distilled off under reduced pressure to obtain 2-nonadecyl-1-octadecylimidazole hydrochloride (0.98 g, 100%). 1 H NMR (CDCl3) δ: 0.88 (6H, t), 1.25-1.40 (62H, m),1.80-1.88 (4H, m), 3.02-3.07 (2H, t), 3.96-4.00 (2H, t), 6.97 (1H, d), 7.29 (1H, d).

[0179] [Production Example 11] Synthesis of 2-nonadecyl-1-octadecylimidazolium tetrakis(pentafluorophenyl)borate 2-Nonadecyl-1-octadecylimidazole hydrochloride (0.98 g, 1.57 mmol) obtained in Production Example 10 and lithium tetrakis(pentafluorophenyl)borate diethyl ether complex (1.19 g, 1.57 mmol) were suspended in cyclohexane (30 mL) and stirred at room temperature for 1 hour. Brine was added, the organic phase was washed, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. Drying at 45°C under reduced pressure gave 2-nonadecyl-1-octadecylimidazolium tetrakis(pentafluorophenyl)borate (0.82 g, 94%). 1H NMR (CDCl3) δ: 0.88 (6H, t), 1.25-1.43 (62H, m), 1.66-1.82 (4H, m), 2.81 (2H, t), 3.94 (2H, t), 6.99 (1H, d), 7.03 (1H, d); 19 F NMR (CDCl3) δ: -133.9 (8F, t), -164.1 (4F, t), -167.9 (8F, t).

[0180] [Example 5] Composition containing 2-nonadecyl-1-octadecylimidazole and 2-nonadecyl-1-octadecylimidazolium tetrakis(pentafluorophenyl)borate 2-Nonadecyl-1-octadecylimidazole (24.1 mg, 0.04 mmol) obtained in Production Example 9 and 2-nonadecyl-1-octadecylimidazolium tetrakis(pentafluorophenyl)borate (126.7 mg, 0.1 mmol) obtained in Production Example 11 were dissolved in cyclohexane (0.5 mL) to obtain a 20% by weight cyclohexane solution. The solution was concentrated under reduced pressure to obtain the title composition. 1 H NMR (CDCl3) δ: 0.88 (6H, t), 1.22-1.33 (62H, m), 1.66-1.82 (4H, m), 2.81 (2H, t), 3.94 (2H, t), 6.99 (1H, d), 7.03 (1H, d); 19 F NMR (CDCl3) δ: -133.9 (8F, t), -164.1 (4F, t), -167.9 (8F, t).

[0181] It was confirmed that the composition obtained in Example 5 was soluble in cyclohexane at a concentration of 20% by weight.

[0182] [Production Example 12] Synthesis of 2-heptadecyl-1-octadecylbenzimidazole 2-Heptadecyl-1H-benzimidazole (1.5 g, 4.2 mmol), obtained by a method similar to that of a publicly known example (e.g., Australian Journal of Chemistry (2015), 68 (1), 145-155), potassium carbonate (1.1 g, 8.0 mmol) and 1-bromooctadecane (1.5 g, 4.5 mmol) were mixed in DMF (30 mL), and the mixture was stirred at 60° C. for 16 hours. The reaction mixture was cooled to room temperature and poured into water. The suspension was stirred at room temperature for 1 hour, and the precipitate was collected by filtration. The obtained solid was dried at 80° C. under reduced pressure to obtain the title compound (2.25 g, 88%). 1 H NMR (CDCl3) δ: 0.88-0.92 (6H, m), 1.25-1.45 (60H, m), 1,75-1.93 (4H, m), 2.84 (2H, t), 4.08 (2H, t), 7.196-7.30 (3H, m), 7.70-7.73 (1H, m).

[0183] [Production Example 13] 2-Heptadecyl-1-octadecylbenzimidazolium tetrakis(pentafluorophenyl)borate 2-Heptadecyl-1-octadecylbenzimidazole (0.61 g, 1.0 mmol) obtained in Production Example 12 and lithium tetrakis(pentafluorophenyl)borate triethyl ether complex (0.91 g, 1.0 mmol) were suspended in cyclohexane (30 mL), and then 1.0 M hydrogen chloride-diethyl ether solution (1.0 mL) was added dropwise and stirred at room temperature for 3 hours. The resulting suspension was filtered, and the filtrate was concentrated under reduced pressure at 50°C to obtain the title compound (1.22 g, 80%). 1 H NMR (CDCl3) δ: 0.88 (6H, t), 1.22-1.44 (60H, m), 1.86-1.92 (4H, m), 3.10 (2H, t), 4.28 (2H, t), 7.58-7.70 (4H, m); 19F NMR (CDCl3) δ: -134.0 (8F, m), -163.7 (4F, t), -167.7 (8F, t).

[0184] [Example 6] Composition containing 2-heptadecyl-1-octadecylbenzimidazolium tetrakis(pentafluorophenyl)borate and 2-heptadecyl-1-octadecylbenzimidazole 2-Heptadecyl-1-octadecylbenzimidazolium tetrakis(pentafluorophenyl)borate (500 mg, 0.4 mmol) obtained in Production Example 13 and 2-heptadecyl-1-octadecylbenzimidazole (47 mg, 0.15 mmol) obtained in Production Example 12 were mixed, and n-hexane was added. The mixture was concentrated under reduced pressure and then dried under reduced pressure for 16 hours to obtain the title composition. 1 H NMR (CDCl3) δ: 0.88(6H, t), 1.16-1.41 (60H, m), 1.84-1.91 (4H, m), 3.06 (2H, t), 4.25 (2H, t), 7.44-7.63 (4H, m); 19 F NMR (CDCl3) δ: -133.9 (8F, d), -164.0 (4F, t), -167.9 (8F, t).

[0185] It was confirmed that the composition obtained in Example 6 was soluble in n-hexane at a concentration of 10% by weight.

[0186] [Example 7] Composition containing 2-nonadecyl-5-octadecoxypyridinium tetrakis(pentafluorophenyl)borate and tetradecyl ether 2-Nonadecyl-5-octadecoxypyridinium tetrakis(pentafluorophenyl)borate (39 mg, 0.03 mmol), tetradecyl ether (12.3 mg, 0.03 mmol) and n-hexane (351 mg) were mixed and stirred at 25° C. The mixture became a homogeneous solution. The mixture was concentrated under reduced pressure and then dried at 50° C. under reduced pressure to obtain the title composition. 1 H NMR (CDCl3) δ: 0.86-0.90 (12H, m), 1.23-1.84 (114H, m), 2.91 (2H, t), 3.41 (4H, t), 4.03 (2H, t), 7.62 (1H, d), 7.85-7.89 (2H, m); 19 F NMR (CDCl3) δ: -134.1 (8F,t), -163.4 (4F,t), -167.4 (8F, t).

[0187] It was confirmed that the composition obtained in Example 7 was soluble in n-hexane at a concentration of 10% by weight.

[0188] [Example 8] Composition containing 2,6-di(nonadecyl)pyridinium tetrakis(pentafluorophenyl)borate and tetradecyl ether 2,6-Di(nonadecyl)pyridinium tetrakis(pentafluorophenyl)borate (39 mg, 0.03 mmol) obtained in Production Example 4, tetradecyl ether (12.3 mg, 0.03 mmol) and n-hexane (351 mg) were mixed and stirred at 25° C. The mixture became a homogeneous solution. The mixture was concentrated under reduced pressure and then dried at 50° C. under reduced pressure to obtain the title composition. 1 H NMR (CDCl3) δ: 0.88 (12H, t), 1.25-1.40 (76H, m), 1.52-1.60 (4H, m), 1.70-1.78 (4H, m), 2.97 (4H, t), 3.39 (4H, t), 7.57 (2H, d), 8.28 (1H, t); 19F NMR (CDCl3) δ: -138.8 (8F,s), -163.6 (4F,t), -167.7 (8F, t).

[0189] It was confirmed that the composition obtained in Example 8 was soluble in n-hexane at a concentration of 10% by weight.

[0190] [Example 9] Composition containing 2-heptadecyl-1-octadecylbenzimidazolium tetrakis(pentafluorophenyl)borate and tetradecyl ether 2-Heptadecyl-1-octadecylbenzimidazolium tetrakis(pentafluorophenyl)borate (39 mg, 0.03 mmol) obtained in Production Example 13, tetradecyl ether (12.3 mg, 0.03 mmol) and n-hexane (351 mg) were mixed and stirred at 25°C. The mixture became a homogeneous solution. The mixture was concentrated under reduced pressure and then dried at 50°C under reduced pressure to obtain the title composition. 1 H NMR (CDCl3) δ: 0.85-0.88 (12H, m), 1.22-1.57 (82H, m), 1.85-1.91 (4H, m), 3.09 (2H, t), 3.38 (4H, t), 4.27 (2H, t), 7.56-7.60 (2H, m), 7.62-7.70 (1H, m); 19 F NMR (CDCl3) δ: -133.9 (8F,s), -163.7 (4F,t), -167,7 (8F, m).

[0191] It was confirmed that the composition obtained in Example 9 was soluble in n-hexane at a concentration of 10% by weight.

[0192] [Example 10] Composition containing 2-nonadecyl-1-octadecylimidazolium tetrakis(pentafluorophenyl)borate and tetradecyl ether 2-Nonadecyl-1-octadecylimidazolium tetrakis(pentafluorophenyl)borate (39 mg, 0.03 mmol) obtained in Production Example 11, tetradecyl ether (73.8 mg, 0.15 mmol) and n-hexane (351 mg) were mixed and stirred at 25° C. The mixture became a homogeneous solution. The mixture was concentrated under reduced pressure and then dried at 50° C. under reduced pressure to obtain the title composition. 1 H NMR (CDCl3) δ: 0.84-0.90 (36H, m), 1.11-1.83 (302H, m), 2.85-2.89 (2H, m), 3.93 (20H, t), 4.00 (2H, t), 7.10 (1H, d), 7.13 (1H, d); 19 F NMR (CDCl3) δ: -134.0 (8F,s), -163.6 (4F, t), -167.7 (8F, t).

[0193] It was confirmed that the composition obtained in Example 10 was soluble in n-hexane at a concentration of 10% by weight.

[0194] [Comparative Example 1] N,N-Dioctadecylanilinium tetrakis(pentafluorophenyl)borate N,N-dioctadecylaniline (3.3g, 5.5mmol) and lithium tetrakis(pentafluorophenyl)borate triethyl ether complex (5.0g, 5.5mmol) were suspended in n-hexane (50mL), and then 1.0M hydrogen chloride-diethyl ether solution (5.5mL) was added dropwise and stirred at room temperature for 3 hours. The resulting suspension was filtered, and the filtrate was concentrated under reduced pressure at 50°C to obtain the title compound (7.0g, 90%). 1 H NMR (CDCl3) δ: 0.86-0.89 (6H, m), 1.15-1.50 (27H, m) 3.40-3.50 (4H, m),7.26-7.28 (2H, m), 7.58-7.63 (3H, m); 19F NMR (CDCl3) δ: -133.8 (8F, t), -163.3(4F, t), -167.4 (8F, t).

[0195] The compound obtained in Comparative Example 1 was poorly soluble in n-hexane at a concentration of 20% by weight.

[0196] [Production Example 14] Synthesis of 2-nonadecyl-5-octadecoxypyridine hydrochloride To a suspension of 2-nonadecyl-5-octadecoxypyridine (1.0 g, 1.6 mmol) obtained in Production Example 6 and n-hexane (100 mL), 1 M hydrogen chloride-diethyl ether solution (10 mL) was added at room temperature and stirred for 1 hour. The solvent of the reaction suspension was distilled off under reduced pressure to obtain 2-nonadecyl-5-octadecoxypyridine hydrochloride (0.98 g, 93%). 1 H NMR (CDCl3) δ: 0.88 (6H, t), 1.24-1.50 (64H, m), 1.78-1.85 (4H, m), 3.13 (2H, t),4.06 (2H, t), 7.74 (1H, d), 7.74 (1H, dd), 8.21 (1H, d).

[0197] [Comparative Example 2] 2-Nonadecyl-5-octadecoxypyridinium tetrakis(pentafluorophenyl)borate 2-Nonadecyl-5-octadecoxypyridine hydrochloride (0.25 g, 0.38 mmol) obtained in Production Example 14 and lithium tetrakis(pentafluorophenyl)borate diethyl ether complex (0.29 g, 0.38 mmol) were suspended in cyclohexane (50 mL) and stirred at room temperature for 1 hour. The organic phase was washed with saline, dried over anhydrous magnesium sulfate, and concentrated under reduced pressure. The residue was dried under reduced pressure at 45°C to obtain the title compound (0.45 g, 90%). 1H NMR (CDCl3) δ: 0.86-0.90 (6H, m), 1.23-1.43 (64H, m), 1.72-1.86 (4H, m), 2.92 (2H, t), 4.03 (2H, t), 7.64 (1H, d), 7.85 (1H, d), 7.91 (1H, dd); 19 F NMR (CDCl3) δ: -134.0 (8F, t), -163.4 (4F, t), -167.5 (8F, t).

[0198] The compound obtained in Comparative Example 2 was poorly soluble in n-hexane at a concentration of 20% by weight.

[0199] [Comparative Example 3] N,N-Dinonylanilinium tetrakis(pentafluorophenyl)borate N,N-Dinonylaniline (0.98g, 2.8mmol) and lithium tetrakis(pentafluorophenyl)borate triethyl ether complex (2.54g, 2.8mmol) were suspended in n-hexane (30mL), and then 1.0M hydrogen chloride-diethyl ether solution (2.8mL) was added dropwise and stirred at room temperature for 2 hours. The resulting suspension was filtered, and the residue was washed with chloroform. The filtrate was concentrated under reduced pressure at 50°C to obtain the title compound (2.19g, 76%). 1 H NMR (CDCl3) δ: 0.84 (6H, t), 1.14-1.56 (64H, m), 3.43 (4H, br), 7.29 (2H, d), 7.56-7.60 (3H, m); 19 F NMR (CDCl3) δ: -133.5 (8F, t), -163.4 (4F, t), -167.4 (8F, t)

[0200] The compound obtained in Comparative Example 3 was poorly soluble in n-hexane at a concentration of 20% by weight.

[0201] [Comparative Example 4] Composition containing N,N-dinonylanilinium tetrakis(pentafluorophenyl)borate and N,N-dinonylaniline When n-hexane (500 mg) was added to the N,N-dinonylanilinium tetrakis(pentafluorophenyl)borate (125 mg, 0.12 mmol) obtained in Comparative Example 3 to prepare a 20 wt% n-hexane solution, the solution separated into two layers. N,N-dinonylaniline (430 mg, 1.25 mmol) was further added to the solution, stirred, and allowed to stand overnight, but the solution separated into two layers. From this, it was found that the title composition was poorly soluble in n-hexane at a concentration of 20 wt%.

[0202] [Comparative Example 5] Compositions containing bis(hydrogenated tallow alkyl)methylammonium tetrakis(pentafluorophenyl)borate and bis(hydrogenated tallow alkyl)methylamine Bis(hydrogenated tallow alkyl)methylammonium tetrakis(pentafluorophenyl)borate (used as [Comparative Example 6] in the following test examples) (133.2 mg) obtained by a method known per se (JP Patent Publication 2000-507157) and bis(hydrogenated tallow alkyl)methylamine (Armin M2HT (registered trademark)) (11.2 mg) were mixed with n-hexane (533 mg) and stirred at room temperature. The mixture became a homogeneous solution. The title compound was obtained by concentrating the mixture under reduced pressure. 19 F NMR (CDCl3) δ: -134.1 (8F, d), -163.0 (4F, t), -167.3 (8F, t).

[0203] [Test Example] (Polymerization Performance Evaluation) A typical polymerization method using the compound or composition of the present invention as a cocatalyst is shown below.

[0204] In a glove box, 1-octene, triisobutylaluminum (TIBA, 0.55M n-hexane solution), and solvent (methylcyclohexane (MCH)) were added to a 100mL autoclave to prepare a comonomer solution. A polymerization catalyst (dimethylsilylene(tert-butylamido)-(tetramethylcyclopentadienyl)-titanium(IV)-dichloride (CGC)), triisobutylaluminum (0.55M n-hexane solution), and solvent were added to prepare a catalyst solution of a predetermined concentration, which was then transferred to a Schlenk flask. A cocatalyst was dissolved in the solvent to prepare a cocatalyst solution of a predetermined concentration, which was then transferred to a Schlenk flask. The total amount of solvent and the total amount of triisobutylaluminum were adjusted to be constant during the reaction after mixing the comonomer solution, catalyst solution, and cocatalyst solution. After purging the autoclave with ethylene gas, the catalyst solution and the cocatalyst solution were added to the autoclave in sequence, and the ethylene pressure was immediately adjusted to a predetermined pressure and stirred at a predetermined temperature (25°C) for a predetermined time. After cooling the reaction mixture on ice and venting the ethylene gas, the mixture was poured into methanol (100mL) containing hydrochloric acid (3mL) and stirred at room temperature for 30 minutes. The precipitate was collected by filtration and dried at 60°C under reduced pressure to obtain an ethylene-octene copolymer.

[0205] (Melting point measurement) Differential scanning calorimetry (DSC) measurements were performed using a DSC6220 instrument (Seiko Instruments Inc.) and the sample (polymer) was heated from 40° C. to 150° C. at a rate of 10° C. / min to measure the melting point.

[0206] The results of the polymerization reaction at 25° C. using various cocatalysts are shown in Table 1.

[0207] [Table 1]

[0208] According to Table 1, it was confirmed that Examples 1, 3 and 4 all exhibited polymerization activity equal to or higher than that of Comparative Examples 1, 5 and 6. [Industrial Applicability]

[0209] The composition of the present invention is useful as a cocatalyst for the polymerization of olefins and dienes since it is soluble (or easily soluble) in hydrocarbon solvents, particularly aliphatic hydrocarbon solvents, and does not poison the catalyst.

[0210] This application is based on Japanese Patent Application No. 2020-043246 filed on March 12, 2020, and Japanese Patent Application No. 2020-209070 filed on December 17, 2020, the contents of which are incorporated in their entirety herein.

Claims

1. (I) a base A, or The following formula (5): [Formula 1] [In the formula, R and R′ each independently represent an optionally substituted C 1-30 Alkyl group, optionally substituted C 3-15 Cycloalkyl group or optionally substituted C 6-14 represents an aryl group. Compounds having a total of 8 or more carbon atoms, (II) The following formula (1): [chemical 2] [In the formula, R 1 , R 2 , R 3 and R 4 all represent a pentafluorophenyl group, and [A-H] + represents a cation derived from base A. Here, the base A represents pyridine, imidazole, or benzimidazole having a total of 25 or more carbon atoms substituted with two identical or different C14-30 alkyl groups or C14-30 alkoxy groups. A composition comprising a compound represented by the formula:

2. The composition of claim 1 , wherein component (I) is a base A.

3. The composition according to claim 1 , wherein the component (I) is a compound represented by the formula (5).

4. The composition according to claim 1 or 2, wherein the content of the base A relative to 1 mole of the compound represented by the formula (1) is in the range of 0.01 to 10 moles.

5. R and R′ are each independently C 1-30 4. The composition according to claim 1, wherein R and R' are alkyl groups and the total number of carbon atoms in R and R' is 8 or more.

6. R and R′ are each independently C 1-304. The composition according to claim 1, wherein R and R' are alkyl groups and the total number of carbon atoms in R and R' is 16 or more.

7. The composition according to any one of claims 1, 3, 5, and 6, wherein the content of the compound represented by formula (5) is in the range of 0.1 to 10 moles relative to 1 mole of the compound represented by formula (1).

8. A cocatalyst for the polymerization of at least one monomer selected from the group consisting of olefins and dienes, comprising the composition according to any one of claims 1 to 7.

9. Formula (3): [C3] [In the formula, R 1 , R 2 , R 3 and R 4 all represent a pentafluorophenyl group. The method for producing the composition according to any one of claims 1, 2, and 4, comprising reacting a compound represented by the formula (3) with the base A, and using more than 1 mole of the base A relative to 1 mole of the compound represented by the formula (3).

10. The method according to claim 9, wherein the amount of base A used is in the range of 1.01 to 3 moles per mole of the compound represented by formula (3).

11. Formula (4): [C4] [In the formula, R 1 , R 2 , R 3 and R 4 all represent a pentafluorophenyl group, M represents an alkali metal or an alkaline earth metal; and n represents 1 or 2. The method for producing the composition according to any one of claims 1, 2, and 4, comprising reacting a compound represented by the formula (4) with the base A and a protonic acid, and using more than 1 mole of the base A relative to 1 mole of the compound represented by the formula (4).

12. Formula (4): [C5] [In the formula, R 1 , R 2 , R 3 and R 4 all represent a pentafluorophenyl group, M represents an alkali metal or an alkaline earth metal; and n represents 1 or 2.], 1 mole of the base A relative to 1 mole of the compound represented by formula (4), and a protonic acid; and then, 0.1 mole or more of a compound represented by formula (5): [C6] [In the formula, R and R′ each independently represent an optionally substituted C 1-30 Alkyl group, optionally substituted C 3-15 Cycloalkyl group or optionally substituted C 6-14 represents an aryl group. The method for producing the composition according to any one of claims 1, 3, and 5 to 7, comprising adding a compound having a total carbon number of 8 or more, represented by the following formula:

13. A method for producing a polymer, comprising polymerizing at least one monomer selected from the group consisting of olefins and dienes by using the composition according to any one of claims 1 to 7 as a cocatalyst.

Citation Information

Patent Citations

  • Highly soluble olefin polymerization catalyst activator

    JP2000507157A

  • Compounds, methods of making them, and methods of using same in catalyst compositions for the production of polyolefins

    JP2003518516A

  • Method for producing tetrakis(fluoroaryl)borate

    JP2007530673A

  • Production method of organic solvent solution of pentafluorophenyl borate salt

    JP2018104335A

  • Trialkylammonium tetrakis (pentafluorophenyl) borate compound-containing composition and method for producing the same

    JP2019059795A